who ya gonna call? wallbusters!
Followers | 289 |
Posts | 10,327 |
Boards Moderated | 1 |
Alias Born | 09/17/2010 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PolyMedix to Present at the NYSSA Biotech and Specialty Pharmaceutical Conference
Nov. 29, 2010 (Business Wire) -- PolyMedix, Inc. (OTC BB: PYMX), a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, announced today that Nicholas Landekic, President & CEO of PolyMedix, will present at the New York Society of Security Analysts 14th Annual Biotech and Specialty Pharmaceutical Conference on Tuesday, November 30, 2010 at 1:35 p.m. Eastern Time.
A live webcast of Mr. Landekic’s presentation will be available at: http://investor.shareholder.com/media/eventdetail.cfm?eventid=86224&CompanyID=ABEA-4ITCYZ&e=1&mediaKey=AA30477493DD80F026CCF4C7874D5D89 or on the Company’s website at www.polymedix.com. A replay will be available on both sites for 90 days following the event.
About PolyMedix, Inc.
PolyMedix is a publicly traded biotechnology company focused on the development of novel drugs for the treatment of serious infectious diseases and acute cardiovascular disorders. PolyMedix uses a rational drug design approach to create non-peptide, small-molecule drug candidates. PolyMedix’s lead antibiotic compound, PMX-30063, is currently in Phase 2 clinical trials. PMX-30063 is a small-molecule that mimics the mechanism of action of human host defense proteins, a mechanism that is distinct from currently approved antibiotic drugs and is intended to make bacterial resistance unlikely to develop. PolyMedix plans to develop this compound for serious systemic Staphylococcal infections, including methicillin resistant Staphylococcus aureus (MRSA). PolyMedix’s lead heptagonist compound, PMX-60056, has completed Phase 1 testing and is being developed to reverse the anticoagulant activity of both heparin and low molecular weight heparins (LMWH). PolyMedix believes that PMX-60056 could potentially be a safer and easier to use anticoagulant reversing agent, with broader activity, than the currently approved therapy for reversing heparin and LMWH. In addition to its small molecule therapeutics, PolyMedix has polymeric formulations with the same mechanism of action as PMX-30063, PolyCides™. PolyCides are intended for use in antimicrobial biomaterials applications as additives to paints, plastics, and textiles to create self-sterilizing products and surfaces. For more information, please visit our website at www.polymedix.com.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause PolyMedix’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward looking statements. PolyMedix has in some cases identified forward-looking statements by using words such as “anticipates,” “believes,” “hopes,” “estimates,” “looks,” “expects,” “plans,” “intends,” “goal,” “potential,” “may,” “suggest,” and similar expressions. Among other factors that could cause actual results to differ materially from those expressed in forward-looking statements are PolyMedix’s need for, and the availability of, substantial capital in the future to fund its operations and research and development, and the fact that PolyMedix’s compounds may not successfully complete pre-clinical or clinical testing, or be granted regulatory approval to be sold and marketed in the United States or elsewhere. A more complete description of these risk factors is included in PolyMedix’s filings with the Securities and Exchange Commission. You should not place undue reliance on any forward-looking statements. PolyMedix undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
PolyMedix, Inc.
Lisa Caperelli, 484-598-2406
Director, Investor Relations & Corporate Communications
lcaperelli@polymedix.com
Source: Business Wire (November 29, 2010 - 8:27 AM EST)
News by QuoteMedia
www.quotemedia.com
TV Goods to Launch National Marketing Campaign for Nasal SoftStrips(TM)
Nasal SoftStrips(TM) Use 100 Percent Natural FDA Market-Approved Essential Oils and Vapors That Are Known to Have Health Benefits
Nov. 29, 2010 (Marketwire) --
CLEARWATER, FL -- (Marketwire) -- 11/29/10 -- TV Goods Holding Corporation ("TV Goods"), a direct response marketing organization and wholly owned subsidiary of H & H Imports, Inc. (OTCBB: HNHI), announced it has acquired exclusive marketing rights to Nasal SoftStrips™. Developed by doctors and medical professionals, Nasal SoftStrips™ are a revolutionary new product approved by the FDA to manage and improve your health and wellness.
Nasal SoftStrips™ are designed to deliver therapeutic blends of essential oils to provide simple, safe and effective solutions to manage and improve your health and wellness. Scientific studies have proven certain scents can help to control appetite, promote relaxation, control nausea, and assist with smoking cessation among other things. Nasal SoftStrips™ are small strips that bend comfortably to the septum of the nose. For more information, please visit www.nasalsoftstrips.com.
TV Goods acquired global marketing rights for multiple distribution channels Nasal SoftStrips™. TV Goods will produce an infomercial spot geared toward the consumer market aimed to drive retails sales to big box and other national and local retailers.
"This is a great, simple, FDA-approved way to suppress appetite. We are excited to produce a spot for this and bring it to retail," said Steve Rogai, CEO of TV Goods Holding Corporation.
About The Company:
H & H Imports, Inc. is the parent company of TV Goods Holding Corporation. TV Goods Holding Corporation is a direct response marketing company. We identify, develop and market consumer products for global distribution. TV Goods was established by Kevin Harrington, a pioneer and principal architect of the "infomercial" industry. Kevin Harrington is an original investor on the ABC show Shark Tank, which is owned by SONY Pictures and produced by reality TV mogul Mark Burnett. TV Goods management is responsible for over 500 infomercial spots accounting for over $4 billion in sales revenues. For more information go to www.TVGoodsInc.com.
Forward-Looking Statements:
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
Contact:
TV Goods Holding Corporation
Kathryn Goodbread
kgoodbread@tvgoodsinc.com
727-474-0598
Source: Marketwire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Mymetics Secures New Patent for Virosome Based Vaccines
Nov. 29, 2010 (Marketwire) --
EPALINGES, SWITZERLAND -- (Marketwire) -- 11/29/10 -- Mymetics Corporation (OTCBB: MYMX), a pioneer in the development of vaccines preventing early transmission of human infectious diseases, announced today that the United States Patent and Trademark Office has issued a notice of allowance for the patent application "Phospholipid Virosome" # 10/544,939, based on WO 04/071492.
Dr. Toon Stegmann, CSO of Mymetics BV, said, "This patent not only allows Mymetics to use a production method that results in better yields and provides an increased activity of virosome vaccines, but it also allows Mymetics to develop virosome based vaccines on any other enveloped virus than flu."
Jacques-François Martin, CEO of Mymetics, added "This patent complements very well the intellectual property portfolio around Mymetics' vaccine pipeline and broadens, in particular, our technology platform to develop other non-influenza virosome based vaccines. It is also an additional confirmation of the importance of our acquisition of Virosome Biologicals last year."
Mymetics already uses this new innovative production method for its Respiratory Syncytial Virus (RSV) and Herpes Simplex Virus (HSV) vaccine that are in preclinical development.
The patent, which describes a method for the production of virosome vaccines based on a short-chain phospholipid, was developed by Mymetics BV in collaboration with the University of Groningen, in the Netherlands. Mymetics BV was formerly known as Virosome Biologicals, which was acquired by Mymetics Corporation in April 2009.
Since the opposition period for the European equivalent of the patent ended at the same time, without opposition being filed, and considering that patent was also granted in most Asian countries, the key technology that will be the basis for Mymetics' future vaccines is now secure.
About Virosomes
A virosome is a drug or vaccine delivery mechanism consisting of a lipid membrane based on an enveloped virus. This membrane can incorporate virus derived proteins to allow the virosomes to fuse with target cells or it can be used as the full natural membrane and proteins of the virus to develop an appropriate vaccine. Virosomes are not able to replicate but are pure fusion-active vesicles. The safety and efficacy of the original virosome technology, which is based on the influenza envelope, has been approved in more than 40 countries for two vaccines developed and marketed by Crucell, one for influenza and one for Hepatitis A.
About Mymetics
Mymetics Corporation is a Swiss-based biotechnology company registered in the US (OTC BB: MYMX) developing next-generation preventative vaccines for infectious diseases. Mymetics' core technology and expertise are based on the use of virosomes, lipid-based carriers containing functional fusion viral proteins, in combination with rationally designed antigens. The company's vaccines are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, which for some pathogens may be essential for the development of an effective vaccine. Mymetics is led by an international and experienced management team and is supported by a strong Scientific Advisory Board composed of renowned experts. The company has established contacts with world leaders in vaccine development.
Mymetics currently has 5 vaccines in its pipeline: HIV-1/AIDS, Influenza, Respiratory Syncytial Virus, Malaria and Herpes Simplex Virus. The company's HIV vaccine is entering a new proof-of-concept preclinical trial following unprecedented results in a first study, and is also currently in a Phase I clinical trial in human volunteers. A Phase 1b clinical trial for its Malaria vaccine on children in Tanzania has been completed, while RSV and HSV vaccine candidates are in the preclinical phase. The Influenza vaccine has been out-licensed to Solvay Pharmaceuticals (now Abbott). For further information, please visit www.mymetics.com.
Forward looking statements
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements, which are identified by the words "believe," "expect," "anticipate," "intend," "plan" and similar expressions. The statements contained herein which are not based on historical facts are forward-looking statements that involve known and unknown risks and uncertainties that could significantly affect our actual results, performance or achievements in the future and, accordingly, such actual results, performance or achievements may materially differ from those expressed or implied in any forward-looking statements made by or on our behalf. These risks and uncertainties include, but are not limited to, risks associated with our ability to successfully develop and protect our intellectual property, our ability to raise additional capital to fund future operations and compliance with applicable laws and changes in such laws and the administration of such laws. See Mymetics' most recent Form 10-K for a discussion of such risks, uncertainties and other factors. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date the statements were made.
Contact:
Ronald Kempers
CFO and COO
Mymetics Corporation
Tel: +41 21 653 4535
U.S. Media:
Michelle Linn
Linnden Communications
Tel: 508-362-3087
Email: Email Contact
Europe Media:
Christophe Lamps
Senior Partner
Dynamics Group
Mobile: + 41 79 476 26 87
Email: Email Contact
Source: Marketwire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Lightlake Therapeutics, Inc. Secures Distinguished Executive as Chairman
LLTP Attaches Valuable Asset to Executive Staff
Nov. 29, 2010 (GlobeNewswire) --
LONDON, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Lightlake Therapeutics, Inc. (OTCBB:LLTP), announces today that the company has secured seasoned healthcare executive Dr. Michael Sinclair to serve as its Executive Chairman. Dr. Sinclair will be instrumental in developing financing options but will be primarily leading the board of directors in strategy and business development.
Michael Sinclair qualified as a physician in 1967 and specialized in Psychiatry. In 1971 he founded Nestor Plc which grew to become at the time, the UK's largest domiciliary and institutional provider of care personnel. Dr Sinclair was Chief Executive of Nestor's parent company which was sold in 1978. His tenure as CEO of Nestor resulted in a compound IRR of 38% over an 8 year period for its shareholders.
Between 1978 thru 1980 he served as President (International) of INA Healthcare Group (subsequently CIGNA) and its Hospital Affiliates Inc subsidiary.
In 1982 Dr Sinclair entered the Homecare Industry in the United States and, as Executive Chairman of Kimberly Quality Care, was instrumental in growing KQC from one office in Nashville to a business with a turnover of $1 billion becoming the US market leader with 400 offices and 75,000 care givers. Subsequently, Dr Sinclair also became Chairman of Lifetime Corporation, a NYSE listed company which was the parent of KQC. Lifetime was sold to Olsten Corporation in 1993. At the end of his tenure in 1993, Dr. Sinclair had generated a compound annual IRR for his original investors of 28% over a period of 11 years.
In 1997 he led the purchase of Nursefinders, a major US nursing personnel business, on behalf of US fund Atlantic Medical; a fund he had founded and where he served as Managing Partner.?Dr Sinclair has built both private and public healthcare businesses, building hospitals such as the Portland in London (his personal vision to establish the first dedicated private hospital in the UK for women and children) as well as care facilities and hospitals in the US, Middle East, Far East, Australia and the UK. He serves on the Board of Overseers (Emeritus) of Tufts University Medical School; where, together with Dean Mort Madoff, he founded the US' first combined MD/MBA program. He is Chairman of Symthera Inc; Care Capital Group plc and Emess Biosciences Ltd..
Michael Sinclair commented: "It is a privilege to join the Board of Lightlake Therapeutics as its Executive Chairman. I have known and admired Dr David Sinclair for almost 20 years. Whilst not blood relatives, we share both a name and a passion for striving to address the only major health problem in the developed world that is getting worse, and which in the United States carries a cost in excess of $147 billion per year. We believe that Lightlake's patented solution to binge eating will play an important part in turning the tide of the obesity epidemic which has been stated to be the only way to show real savings in health expenditures in the future."
Dr Roger Crystal, CEO of Lightlake, commented: "I am delighted to welcome Mike to the team. His vast experience in healthcare will be of great benefit to the company."
About Lightlake Therapeutics, Inc.
Lightlake Therapeutics is an international team of research scientists, pharmacologists and doctors backed by investors, who are pioneering the search for a safe, effective and simple treatment for the epidemic of obesity and unhealthy eating. Its expertise is derived from an existing treatment that has recorded a 78% success rate in treating the over consumption of alcohol.
Lightlake is pioneering the treatment of one of the world's biggest killers and will be initially focused on addressing obesity caused by binge eating -- thought to be prevalent in one in three obese people. To date existing pharmacological interventions have failed to deliver a sustainable solution to the obesity epidemic Lightlake's approach is unique through using a single compound with known safety as a nasal spray. In addition, it is unlikely that patients will require this medication in a regular lifelong manner, which is a significant departure from existing anti-obesity medication.
Dr. David Sinclair, Ph.D., Lightlake's Chief Science Officer, says:
"Delivery is through a pocket sized nasal spray that is easy and convenient to carry. The treatment begins working progressively from the first day to reduce the urge to eat unhealthily. One of the real marvels of the treatment is that it changes what you think about. Dieting and most other weight reduction procedures have the opposite effect. They make you think more and more about problem foods."
This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. For those statements, the Company claims the protection of the safe harbor for forward-looking statements provisions contained in the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Such forward-looking statements by definition involve risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from the future results, performance or achievements expressed or implied by such forward-looking statements. In particular, there is no assurance that production, pricing levels or other factors pertaining to the manufacturing and retail operations will be sustained at the expected rates or levels over time. Discussions of factors, which may affect future results, are contained in the Company's most recent SEC filings.
For more information
Visit http://www.lightaketherapeutics.com
CONTACT: Lightlake Therapeutics, Inc
44-207-034-1943
Roger.crystal@lightlake.fi
Source: Globe Newswire (November 29, 2010 - 9:11 AM EST)
News by QuoteMedia
www.quotemedia.com
Lightwave Logic Receives Notice of Allowance in Patent Application for Perkinamine? Chromophores, Protecting Revolutionary Electro-optical Polymer Foundation Technology
Next generation electro-optic polymer material platform now protected by composition of matter claims
Nov. 29, 2010 (PR Newswire) --
NEWARK, Del., Nov. 29, 2010 /PRNewswire/ -- Lightwave Logic, Inc. (OTC Bulletin Board: LWLG), a technology company focused on the development of the 'Next Generation Electro-Optic Polymer Material Platform' for applications in high speed fiber-optic data communications and optical computing, announced that it has received a Notice of Allowance in U.S. Patent Application No. 11/666,320 for Heterocyclical Chromophore Architectures, which is directed to various Perkinamine™ chromophores, the company's base chromophore architecture -- the foundation of its unique electro-optic materials platform.
A chromophore is an advanced type of dye that imparts electro-optical properties to a polymer. Perkinamine™ chromophores are a highly potent class of compounds which impart unparalleled thermal and optical stability to a resulting polymer matrix.
Jim Marcelli, Chief Executive Officer of Lightwave Logic said, "We are very pleased that after thorough prosecution at the USPTO we have received this Notice of Allowance for all seven pending claims. Protection of our Intellectual Property together with our know-how creates enormous value for our shareholders.
It is important to understand that our growing patent portfolio now includes allowed U.S. claims covering many of Lightwave's major compounds which individually can be used in a myriad of electro-optical devices and applications among them being; spatial modulators, amplitude and phase modulators, optical limiters, and optical computers."
Dave Eaton, the company's Chief Technology Officer stated, "Our base chromophore architecture is a powerful component of our advanced next generation electro-optical polymer platform. Together with our previously announced Notice of Allowance for our unique spacer, we now have strengthened protection for the total package required for advanced electro-optic applications in telecom and optical computing applications."
"Powered by Lightwave Logic"
Lightwave Logic, Inc. is a development stage company that is producing prototype electro-optic demonstration devices and is moving toward commercialization of its high-activity, high-stability organic polymers for applications in electro-optical device markets. Electro-optical devices convert data from electric signals into optical signals for use in high-speed fiber-optic telecommunications systems and optical computers. Please visit the Company's website, www.lightwavelogic.com for more information.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.
SOURCE Lightwave Logic, Inc.
Source: PR Newswire (November 29, 2010 - 9:01 AM EST)
News by QuoteMedia
www.quotemedia.com
Titan Chooses EZX Trading Platform and FIX Connectivity
Nov. 29, 2010 (Marketwire) --
EDMONTON, ALBERTA and NEW YORK, NEW YORK -- (Marketwire) -- 11/29/10 -- Titan Trading Analytics Inc. (TSX VENTURE: TTA) (OTCBB: TITAF) ("Titan") announced today that the firm has entered into an agreement with EZX Inc. to license its iServer® trading platform and FIX connectivity software. EZX's iServer® will enable users of Titan's TickAnalyst™ to electronically trade signals generated for equities, futures and currencies.
Established in 2004, EZX provides turnkey trading solutions for over 70 hedge funds and brokers. The iServer® provides seamless integration of FIX connectivity into proprietary trading systems and blackbox strategy engines, enabling the execution of advanced trading strategies through a normalized API. This allows users to undertake development once, and connect everywhere without additional development efforts.
EZX will also provide Titan with FIX connectivity services including monitoring FIX order flow and performing certifications to new endpoints. iServer® is currently FIX certified with nearly 100 brokers, exchanges, and Alternative Trading Systems globally. Titan will host the EZX iServers® in a broker neutral co-location data center.
"We chose EZX for a variety of reasons" stated Titan CEO John Coulter. "FIX engines are a commodity, but most require intensive development time on the application and connectivity side. iServer's® simple API saved us weeks on the application integration to TickAnalyst™. In addition, FIX session certification is extremely time consuming and resource intensive. With EZX we are instantly certified with every major liquidity destination out-of-the-box. EZX will enable our engineers to concentrate on our core products without distraction."
John Petschauer, CEO of EZX commented, "Titan's integration with our iServer® product is a perfect example of how we work with partners. EZX handles the trading infrastructure so Titan can keep their resources focused on delivering great innovative products like TickAnalyst™."
About EZX, Inc.
EZX is a leading independent provider of strategy based trading solutions for Hedge Funds, Asset Managers, Trading Firms, & Brokers. Our high speed, broker neutral trading platform easily integrates directly to your Strategy/Algo engines, proprietary OMS, Custom Trading screens, or Excel spreadsheets. EZX configures, certifies, and supports the entire trading infrastructure so you can stay focused on your core business. For more information on our other products and services, visit www.ezxinc.com.
About Titan
Titan Trading Analytics Inc. is a premier provider of Behavioral Trading Research. Trade signals are distributed via a powerful financial analysis and electronic trading software platform which captures and analyzes real-time market tick data and identifies trade opportunities based on numerous historical patterns, identified by Titan's Trade Recommendation Engine™ (TRE). Titan's flagship product, TickAnalyst™, delivers trading signals to proprietary trading firms and hedge funds via a cutting edge browser-based interface. Titan Trading USA LLC is an asset management group which services high net worth investors and is broker neutral. Titan's internally developed products and services are at the forefront of the high growth global investment management and automated trading industry.
Forward Looking Statements
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the financial crisis in the US, consumer spending, the amount of sales of the Company's products, the competitive environment within the industry, the ability of the Company to continue to expand its operations, the level of costs incurred in connection with the Company's expansion efforts, economic conditions in the industry and the financial strength of the Company's clients. The Company does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties. Accordingly, readers should not place undue reliance on forward looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Titan Trading Analytics Inc.
Audra Tiner, Leadership Team
Articulate Communications Inc.
212-255-0080 ext. 34
atiner@articulatecomms.com
EZX Inc.
Greg Nadan
908-376-1446
greg.nadan@ezxinc.com
www.ezxinc.com
Source: Marketwire (November 29, 2010 - 9:01 AM EST)
News by QuoteMedia
www.quotemedia.com
YANGAROO REPORTS THIRD QUARTER RESULTS
Nov. 29, 2010 (Canada NewsWire Group) --
TORONTO, Nov. 29 /CNW/ - YANGAROO Inc. (TSX-V: YOO, OTC: YOOIF), the industry's leading secure digital media distribution company, today announced its results for the nine months and third quarter ended September 30, 2010. Revenues for the nine month period decreased 8% over revenues for the nine month period of 2009. This change is primarily a result of $81,000 of timing differences in recurring award show revenues that were recognized in the first nine months of 2009, but are to be recognized later in 2010 and in early 2011. The loss for nine months ended September 30, 2010 was 30% ($564,000) higher compared to the same period in 2009, primarily due to bolstering the management team and debenture interest. Increases in recruiting expense of $236,000, interest expense of $100,000, amortization of intangible assets of $60,000 and stock option expense of $38,000 contributed to the increased loss.
Recent period highlights include a multi-year agreement with Viacom's BET Networks to use YANGAROO's Digital Media Distribution System (DMDS) technology for delivery of all artist and music-related audiovisual content to BET properties, an agreement with the Academy of Country Music to power online review and professional member voting for the forthcoming 46th Annual Academy of Country Music Awards and receiving the grant of Canada patent number 2,349,797 titled "Biometric Rights Management System". During the third quarter, YANGAROO named advertising industry veteran Anthony G. Miller to the board of directors and appointed former DG FastChannel Inc. executive Karen Dealy to President of U.S. Advertising Operations. Dealy is working closely with the YANGAROO team on launching the new advertising delivery division, which will offer the advertising community a fast, secure and cost-effective way to deliver HD and SD video as well as audio advertisements to broadcasters.
"This past quarter we made great strides in expanding our reach beyond the music industry to the advertising industry. With the hire of Karen Dealy and naming Anthony Miller to our board, we're forging a winning strategy in this key market. As we meet with key partners, we are seeing that our solution resonates with both agencies and broadcasters," said YANGAROO CEO Scott Wambolt. "With regards to the music industry, we're continuing with our strategy of structuring smart deals with top broadcasters like MTV and BET Networks to accept music video content via DMDS."
Summary of operating results for the periods ended September 30th:
$CDN Nine Months Third Quarter
2010 2009 2010 2009
Revenue 553,553 604,439 171,729 218,211
Interest income 2,854 10,044 2,071 945
EBITDA (1,850,450) (1,452,515) (785,862) (365,996)
Net loss for the period (2,444,938) (1,881,298) (981,287) (545,626)
Loss per share (basic & diluted) (0.03) (0.02) (0.01) (0.01)
The loss for the third quarter of 2010 increased 80% ($436,000) compared to the third quarter of 2009. This increase was primarily due to increases in the general and administrative expense of $233,000 (174%), which includes the higher recruiting expense, and in salaries and consulting expense of $136,000 (36%), plus interest expense of $48,000 on convertible debentures that were issued in the first half of 2010. Timing differences of $47,000 in recurring award show revenues that were recognized in the third quarter of 2009, but are to be recognized later in 2010 and in early 2011 also contributed to the higher loss.
The full text of the financial statements and Management Discussion & Analysis is available at www.yangaroo.com and at www.sedar.com.
About YANGAROO:
YANGAROO's patented Digital Media Distribution System (DMDS) is a leading secure B2B digital delivery solution for the music and advertising industries. DMDS is a Web-based delivery system that pioneers secure digital file distribution by incorporating biometrics, high-value encryption and watermarking. DMDS replaces the physical distribution of audio and video content for music, music videos, and advertising to television, radio, media, retailers, award shows and other authorized recipients with more accountable, effective, and far less costly digital delivery of broadcast quality media via the Internet.
Named one of Canada's Top 100 Tech Companies for 2009 by Canadian Business, YANGAROO has offices in Toronto, New York, Los Angeles, and London, U.K. YANGAROO trades on the TSX Venture Exchange (TSX-V) under the symbol YOO and in the U.S. under OTCBB:YOOIF. For further information, please contact Scott Wambolt at 416-534-0607 ext 111 or visit www.yangaroo.com.
The statements contained in this release that are not purely historical are forward-looking statements and are subject to risks and uncertainties that could cause such statements to differ materially from actual future events or results. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
%SEDAR: 00018809E
Contact:
Gina Preoteasa
Trylon SMR
212/905-6060
gina@trylonsmr.com
Source: Canada Newswire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
Fannie Mae Redemption
WASHINGTON, Nov. 29, 2010 (PR Newswire Europe) --
/PRNewswire/ -- Fannie Mae will redeem the principal amounts indicated for the following securities issues on the redemption dates indicated below at a redemption price equal to 100 percent of the principal amount redeemed, plus accrued interest thereon to the date of redemption:
Principal Security Interest Maturity CUSIP Redemption Amount Type Rate Date Date $50,000,000 MTN 2.000% December 9, 2016 3136FJUT6 December 9, 2010 $60,000,000 MTN 3.000% June 9, 2015 3136FJUU3 December 9, 2010
Fannie Mae exists to expand affordable housing and bring global capital to local communities in order to serve the U.S. housing market. Fannie Mae has a federal charter and operates in America's secondary mortgage market to enhance the liquidity of the mortgage market by providing funds to mortgage bankers and other lenders so that they may lend to home buyers. Our job is to help those who house America.
This press release does not constitute an offer to sell or the solicitation of an offer to buy securities of Fannie Mae. Nothing in this press release constitutes advice on the merits of buying or selling a particular investment. Any investment decision as to any purchase of securities referred to herein must be made solely on the basis of information contained in Fannie Mae's applicable Offering Circular, and that no reliance may be placed on the completeness or accuracy of the information contained in this press release.
You should not deal in securities unless you understand their nature and the extent of your exposure to risk. You should be satisfied that they are suitable for you in the light of your circumstances and financial position. If you are in any doubt you should consult an appropriately qualified financial advisor.
CONTACT: Katherine Constantinou of Fannie Mae, +1-202-752-5403
Source: PR Newswire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
Salamon Group Inc. Files Form 10-Q for the Period Ended September 30, 2010
Nov. 29, 2010 (GlobeNewswire) --
LAS VEGAS, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Salamon Group Inc. (OTCBB:SLMU) is pleased to announce that it has filed its September 30, 2010 Form 10-Q with the Securities and Exchange Commission.
Auditors for Salamon Group Inc. have been changed from Corbin & Company to Manning Elliott, a Vancouver, B.C. Canadian firm.
For further clarification regarding the change of auditors, refer to the news announcement and 8-K filing of November 15, 2010.
Salamon Group Inc. is presently in negotiations with Sunlogics Inc. of Kelowna, B.C. Canada and will keep Shareholders posted on the progress in the way of press releases.
Salamon Group is publicly traded under the symbol SLMU.
About Salamon Group, Inc.
Salamon Group is a development stage company whose aim is to develop, license and/or acquire and develop technologies and concepts in the field of Solar, "Alternative Energy Sources".
Forward-Looking Statements:
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Salamon Group, Inc.'s filings with the Securities and Exchange Commission which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
CONTACT: Salamon Group, Inc.
John Salamon, President & C.E.O.
salamongroup@shaw.ca
Source: Globe Newswire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
Hana Biosciences to Present Data on Marqibo(R) at the 2010 American Society of Hematology Annual Meeting and Exposition
Nov. 29, 2010 (GlobeNewswire) --
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that data regarding Marqibo for treatment of adults with relapsed/refractory acute lymphoblastic leukemia (ALL) will be the subject of two presentations at the 2010 Annual Meeting and Exposition of the American Society of Hematology (ASH) being held in Orlando, Florida from December 4-7, 2010.
Presentation details are as follows:
Abstract: 2142: Marqibo® (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) In Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)
Abstract: 2143: Marqibo® (vincristine sulfate liposomes injection; VSLI) In the Treatment of Adult Patients with Advanced, Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL): A Combined Analysis of the VSLI-06 and RALLY Studies
Date/Time/Place: Sunday, December 5, 2010, 6:00PM – 8:00PM
Orange County Convention Center, Orlando, FL
Poster Boards: II-22 & 23
The abstracts are available online at:
http://ash.confex.com/ash/2010/webprogram/Paper33455.html
http://ash.confex.com/ash/2010/webprogram/Paper34609.html
About Marqibo(R) (vincristine sulfate liposomes injection)
Marqibo is a novel, targeted, Optisome(TM) encapsulated formulation of vincristine sulfate, a widely-used chemotherapy, which has shown promising anti-cancer activity in patients with ALL, non-Hodgkin's lymphoma, Hodgkin's disease, and melanoma in several clinical trials. Marqibo is designed to enhance the penetration and concentration of vincristine sulfate at sites of active cancer and facilitate dose-intensification compared to standard vincristine formulations. Unlike standard vincristine, Marqibo is dosed based on actual patient body surface area without the need for dose capping.
Hana Biosciences has received orphan drug and fast track designations for Marqibo for the treatment of adult ALL from the U.S. Food and Drug Administration. Marqibo has also received orphan drug designation in adult ALL from the European Medicines Evaluation Agency.
About Hana Biosciences, Inc.
Hana Biosciences, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. The company's lead product candidate, Marqibo(R), potentially treats acute lymphoblastic leukemia and lymphomas. The Company has additional pipeline opportunities some of which, like Marqibo, improve delivery and enhance the therapeutic benefits of well characterized, proven chemotherapies and enable high potency dosing without increased toxicity. Additional information on Hana Biosciences can be found at www.hanabiosciences.com.
The Hana Biosciences, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3290
Forward-Looking Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use of words or phrases such as "anticipates," "expects," "plans," "believes," "intends," and similar words or phrases. These forward-looking statements include without limitation, statements regarding the clinical development of Marqibo, the potential of Marqibo to replace existing therapies and the expected benefits Marqibo may have for patients with relapsed ALL and other diseases compared to existing therapies. Such statements involve risks and uncertainties that could cause Hana's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements.
CONTACT: Hana Biosciences, Inc.
Investor & Media Contacts:
Investor Relations Team
(650) 588-6641
investor.relations@hanabiosciences.com
Source: Globe Newswire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
Solar Thin Films, Inc. Enters Into Letter of Intent for Joint Venture
Nov. 29, 2010 (Marketwire) --
NEW YORK, NY -- (Marketwire) -- 11/29/10 -- Solar Thin Films, Inc. (OTCBB: SLTZ) today announced that it has entered into a Letter of Intent with One Globe Renewables, LLC of Colorado, USA for the purpose of forming a joint venture and strategic relationships for the development and syndication of solar farms on both a proprietary and turnkey basis. Preliminary talks are underway in Israel, Canada, Europe and elsewhere to form joint ventures similar to the one being negotiated with One Globe Renewables. The Company describes these negotiations as the first stage of its recently announced shift in focus from the sale of turnkey factories for the production of thin film solar modules through its Hungarian subsidiary and affiliates to concentrate on establishing, financing, managing and syndicating solar farms as power projects both domestically and internationally.
One Globe Renewables, LLC (OGR) is a limited liability company founded in 2010 and based in Colorado. One Globe focuses on the development, financing and power project management of rooftop, carport and ground-mount commercial solar photovoltaic (PV) energy producing assets in all domestic and selected international markets.
Solar Thin Films, Inc. (OTCBB: SLTZ) has manufactured solar module production equipment and turn-key amorphous silicon module factories. The Company is now working to establish itself as an international developer and syndicator of solar power projects.
Source: Marketwire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
Ironwood Gold's Senior Management to Attend Premier UK Industry Mines and Money 2010 Event
Nov. 29, 2010 (Marketwire) --
SCOTTSDALE, AZ -- (Marketwire) -- 11/29/10 -- Ironwood Gold Corp. (OTCBB: IROG) (the "Company") wishes to advise that Senior Management will be in attendance and available for meetings during the upcoming Mines and Money show in London November 30th to December 1st.
The event is considered one of the mining industry's premier trade events and is held annually in the UK. Mines and Money succeeds in providing one of the best forums for miners and financiers to meet, exchange ideas, debate, make and cement business relationships. Now in its eighth year, 2010 promises to deliver another successful event, with a conference program featuring a broad range of expert speakers covering a wide spectrum of issues concerning the miner and mining financier in today's business climate.
Held at the Business Design Centre in Islington, the former Royal Agricultural Hall is only a mile from The City and two from The West End, and can be found at 52 Upper Street, Islington, London N1 0QH. For more information regarding the show, visit: www.minesandmoney.com/london.
The 2009 event saw over 2,800 participants visit the Business Design Centre for an exceptionally busy two-day conference and exhibition. Over 35% of the audience travelled from overseas. The program offers Europe's best forum for networking with senior investors, bankers, analysts and mining executives. The event incorporates a two-day conference offering talks from leading financiers and mining experts, plus an exhibition featuring 150+ companies and concludes with the prestigious Mining Journal Outstanding Achievements Award Dinner.
To arrange for a meeting with Ironwood's management before, during or after the event, please contact:
Laurence Read/ Beth Harris
Threadneedle Communications
Laurence.read@threadneedlepr.co.uk
Tel: +44 (0) 20 7653 9855
Additional details regarding the Company and its agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information visit: www.ironwoodgold.com.
ABOUT IRONWOOD GOLD CORP. (OTCBB: IROG)
Ironwood Gold Corp. is a mineral exploration and development company building a portfolio of prospective properties containing known deposits of strategic precious metals in politically stable, mining-friendly North American districts with recognized production histories.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
Ironwood Gold Corp.
-----------------------------
Behzad Shayanfar, CEO
Add to Digg Bookmark with del.icio.us Add to Newsvine
Investor Information:
Red Oak Communications, Inc.
Phone: 1-888-356-4942
Email: info@ironwoodgold.com
Web: www.ironwoodgold.com
Source: Marketwire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
Zentric, Inc. (ZNTR) Announces Engagement of QualityStocks Investor Relations Services
Nov. 29, 2010 (Marketwire) --
SCOTTSDALE, AZ -- (Marketwire) -- 11/29/10 -- Zentric, Inc. (OTCBB: ZNTR) announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts.
You can SIGN UP NOW http://Signup.QualityStocks.net
Zentric, Inc. has developed a new and revolutionary battery technology to incorporate high voltage dual electrolytes for higher voltages and power. Through innovation, acquisitions and strategic partnerships, the company aims to accelerate the market applicability of advanced battery technologies as well as storage systems.
Zentric's unique battery technology allows specific combinations of key battery components to attain a much higher voltage than traditional lead acid batteries while costing a lot less than lithium-ion batteries. By fitting more energy into the same form factor, the company's technology offers a significant advantage over existing solutions on the market.
Mr. Jeff Mak, President and CEO of Zentric, stated, "ZNTR has a unique and solid business foundation, and appreciates the opportunity to sponsor the QualityStocks Newsletter, Video and Blogs. QualityStocks is providing a much needed service in the micro-cap and small-cap markets."
About Zentric, Inc. (ZNTR)
Zentric, Inc. is an advanced battery technology company based on a new and revolutionary battery technology to incorporate high voltage dual electrolytes to produce higher voltages and power. The technology was developed in the laboratories of the University of Hong Kong for over 10 years.
For more information on Zentric, Inc., visit: http://ZNTR.qualitystocks.net
About QualityStocks
Small Cap Stock Newsletter QualityStocks is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one free Daily Newsletter Report. QualityStocks also utilizes social media and networking to maintain constant communication with its rapidly growing audience. To date, QualityStocks has more than 130,000 users following various Twitter accounts.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
The QualityStocks Blog
The QualityStocks Blog keeps investors up to date on everything related to the Small-Cap and Micro-Cap markets. Alternative fuels and power sources, entertainment media, telecommunications, delivery services, healthcare, and retail are all covered on a regular basis. By visiting our blog, investors also discover emerging companies that they otherwise would not have heard about. To date, more than 20,000 articles have been published via the QualityStocks Blog.
The QualityStocks Message Boards
The message board here at QualityStocks is one of the most highly regulated, no-nonsense forums online today; an uncommon haven of highly relevant, SPAM-free investor interaction. Unlike the majority of boards currently in operation, you won't find pumping, bashing, advertising, or malicious posting of any kind here. The QualityStocks Message Boards has over 34,000 registered users.
The QualityStocks Daily Newsletter
With all of the stock picks and recommendations available today in the investment world, selecting and deciding on the right stocks can be tedious and time consuming. At QualityStocks, we collate hundreds of investment newsletters into The ONE and ONLY "The QualityStocks Daily", featuring a summary format in which you can view the latest stock picks EVERYDAY.
You can SIGN UP NOW http://Signup.QualityStocks.net
Forward-Looking Statements:
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
Astra Thomas
QualityStocks
Scottsdale, Arizona
www.QualityStocks.net
480.374.1336
editor@QualityStocks.net
Source: Marketwire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
GreenMan Technologies' Subsidiary to Partner With the Missouri Association of School Boards to Offer ADA Compliance Services
New Partnership Amends and Extends Business Development Agreement to January 2015
Nov. 29, 2010 (Marketwire) --
CARLISLE, IA -- (Marketwire) -- 11/29/10 -- GreenMan Technologies, Inc. (OTCBB: GMTI), today announced that its subsidiary, Green Tech Products, Inc. through its sales and marketing agreement with Disability Access Consultants ("DAC"), has entered into a partnership with the Missouri School Board Association ("MSBA") to offer ADA compliance services to the more than 500 school districts in the state. Green Tech Products currently provides unique playground safety products to MSBA member school districts and through this agreement, will now offer "DACTrak," a web based inspection software and data management system that will allow the Missouri school districts to effectively evaluate their Americans with Disabilities Act (ADA) compliance and plan solutions.
Ernie Knight, Vice President of Green Tech Products, Inc., commented, "This year marks the 20th anniversary of the signing of the Americans with Disabilities Act, a benchmark that renews the emphasis on ADA compliance. Likewise, the U.S. Department of Justice has recently signed revised ADA regulations and we believe this will lead to an increased focus on ADA compliance in school districts across the country. We look forward to our continued partnership with Missouri schools and to assisting their ADA self-evaluations and in the development of transition plans to bring programs and facilities into compliance without outside mandates. DacTrak is a revolutionary ADA compliance software platform that we believe will greatly enhance the ability of Missouri School Districts in preparing their required compliance to the new regulations."
In May 2010 GreenTech Product's entered into a sales and marketing agreement with DAC for the worldwide commercialization of their unique web based compliance software platform and inspection methods. Headquartered in Las Vegas, Nevada, DAC is a respected leader in providing "accessibility compliance" software products, consulting services and expertise to ensure their clients are in compliance with the federally mandated ADA and related federal, state and local codes. The Americans with Disabilities Act of 1990 ("ADA") mandates that facilities in the United States provide equal access for individuals with disabilities. DAC's dynamic software platform, "DACTrak," simplifies and expedites the evaluation and transition plan process for compliance with ADA and state accessibility regulations. DAC's inspectors or the client, when appropriately trained, can perform an on-site interactive evaluation using a handheld computer tablet utilizing DACTrak. Upon completion of the inspection, the data is uploaded via a secure internet connection to DAC's servers for processing and selecting the applicable state and federal codes. Within minutes a detailed assessment report is available for review. In addition, DAC's web based solution allows a client to view, interact and manage their compliance data on a real time basis in a user friendly format. In contrast, a majority of ADA compliance inspections today take a considerable amount of time to complete; transition plan reports are long paper documents that must be updated manually and are typically difficult to use and understand.
Tim Mahoney, President of Green Tech Products, added, "Based on U.S. Census Bureau's estimate that 54 million people in the United States have some form of disability, the need for DAC's dynamic and cost effective ADA compliance solution has never been greater. We have witnessed significant momentum in the ADA legislation over the past couple of years with the 2008 ADA Amendments Act broadening the definition of a person with a 'disability' and the recently signed 2010 ADA regulations broadening the types of facilities which must comply with the ADA." Mr. Mahoney added, "We have also seen a significant increase in enforcement efforts by the Department of Justice and ADA litigants to ensure greater compliance to this federal law, especially in the public education and hospitality sectors. We are working to make the DACTrak solution the standard by which all others are compared to."
About GreenMan Technologies
GreenMan Technologies, through its subsidiaries, provides technological processes and unique marketing programs for alternative energy, renewable fuels and innovative recycled products. The Company's alternative energy subsidiaries, American Power Group, Inc. (APG) and APG International, Inc. (APGI) provide a cost-effective patented dual fuel technology for diesel engines. APG's dual fuel alternative energy system is a unique external fuel delivery enhancement system that converts existing diesel engines into more efficient and environmentally friendly engines that have the flexibility to run on: 1) diesel fuel and compressed natural gas ("CNG"); 2) diesel fuel and bio-methane, or 3) 100% diesel fuel depending on the circumstances. The proprietary technology seamlessly displaces up to 65% of the normal diesel fuel consumption with CNG or bio-methane and the energized fuel balance between the two fuels is maintained with a patented control system ensuring the engines operate to Original Equipment Manufacturers' ("OEM") specified temperatures and pressures with no loss of horsepower. Installation requires no engine modification unlike the more expensive high-pressure alternative fuel systems in the market. Our Green Tech Products, Inc. subsidiary develops and markets branded products and services that provide schools and other political subdivisions viable solutions for safety, compliance, and accessibility including recycled surfacing. See additional information at: www.greenman.biz, www.americanpowergroupinc.com, and www.playgroundcompliance.com.
"Safe Harbor" Statement: Under the Private Securities Litigation Reform Act
With the exception of the historical information contained in this news release, the matters described herein contain "forward-looking" statements that involve risks and uncertainties that may individually or collectively impact the matters herein described, including but not limited to the fact that we have sold the tire recycling operations which have historically generated substantially all our revenue and that we will be prohibited from competing in that business on a regional basis until 2013; the risk that we may not be able to increase the revenue or improve the operating results of our Green Tech Products or American Power Group divisions; the risk that we may not be able to return to sustained profitability; the risk that we may not be able to secure additional funding necessary to grow our business, on acceptable terms or at all; the risk that if we have to sell securities in order to obtain financing, the rights of our current stockholders may be adversely affected; the risk that we may not be able to increase the demand for our products and services; the risk that we may not be able to adequately protect our intellectual property; and risks of possible adverse effects of economic, governmental, seasonal and/or other factors outside the control of the Company, which are detailed from time to time in the Company's SEC reports, including the Annual Report on Form 10-K for the fiscal year ended September 30, 2009. The Company disclaims any intent or obligation to update these "forward-looking" statements.
Contacts:
Chuck Coppa
CFO
or
Lyle Jensen
CEO
GreenMan Technologies
781-224-2411
Investor Relations Contacts:
Jennifer Belodeau or John Nesbett
Institutional Marketing Services (IMS)
203- 972-9200
Source: Marketwire (November 29, 2010 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
Black Hawk Exploration acquires oil and gas leases in Cowley County, Kansas
Nov. 29, 2010 (M2 Communications Ltd.) --
Metals and energy exploration company Black Hawk Exploration (OTCBB:BHWX.ob) reported on Monday that it has purchased oil and gas leases covering approximately 2,553 acres of land in Cowley County, Kansas.
Black Hawk said that it owns 100% of the leases within the Prospect Area and has an undivided 81.5% working interest in and to the oil and gas leases and their previous 10 shut-in oil and gas wells.
The lease acquisition includes a 100% interest in one shut-in oil/gas well, the #1 Baker, located on the Keith Baker lease, as well as a 100% interest in nine other oil wells that were previously shut- in.
Under Black Hawk’s Oil 2011 Program the company plans to re-work all 10 locations directly or in joint venture with Tiger Oil and Energy Inc (OTCBB:TGRO.ob) and return all of them to cash flow production.
In a separate agreement Tiger Oil & Gas LLC, a Kansas limited liability company, has agreed to operate and participate in the development and exploration of additional oil and gas leases on behalf of Black Hawk.
(Comments on this story may be sent to tww.feedback@m2.com)
Source: M2 Presswire (November 29, 2010 - 8:59 AM EST)
News by QuoteMedia
www.quotemedia.com
Dynamic Ventures Corporation Anticipates its Financials to be filed Imminently
Nov. 29, 2010 (PR Newswire) --
SCOTTSDALE, AZ - Dynamic Ventures Corporation (OTC: BB: DYNV), anticipates its financials to be filed imminently.
On November 15th, 2010 the company filed a NT 10Q with the Security and Exchange Commission (SEC) informing them that the Registrant (DYNV) was unable to complete its audit and preparation of its 10Q in a timely manner due to unanticipated delays. The company was hoping to meet the extension deadline. However, when this date was not met, an "E" was added to the company's trading symbol (DYNVE) to denote the company is late in a required SEC Filing or has submitted an incomplete form. The "E" will be removed once the appropriate filings are submitted to, and approved by the SEC. SEC regulations allows the company a 30 day grace period in which to do so, but the company anticipates its financials to be filed imminently.
"The extensive time it took to prepare interim statements due to the acquisition by Bundled Builder Solutions, Inc, of Floor Art, LLC and Builder Design Center, LLC, which occurred prior to the share exchange agreement. In addition, our September 30th 2010 financials and all related financials had to be redone to give effect to the stock split on November 09th 2010, are just two examples of why our filings required more time then usual." explained Paul Kalkbrenner, President of Dynamic Ventures.
The company appointed a new auditor upon the completion of the merger as well as new legal counsel. As such, the new firms required additional time and due diligence to become familiar with the corporation prior to signing off on the filing.
About The Company:
Dynamic Ventures Corporation, develops and markets efficient construction solutions for residential and commercial buildings. The company offers a turnkey solution enabling the firm to custom design, manufacture and install complete LEED certified structures.
This press release contains forward-looking statements that involve risks and uncertainties, including the Company's beliefs about its business prospects and future results of operations. Some factors that could cause actual results to differ materially include economic and operational risks, changes in anticipated earnings, continuation of current contracts, and other factors detailed in the Company's filings with the Securities and Exchange Commission, including its most recent Forms 10-KSB and 10-QSB. The Company forecasts provided above are dynamic and therefore refer only to this release date. The Company does not undertake to update any forecasts that it may make available to the investing public.
SOURCE Dynamic Ventures Corp.
Source: PR Newswire (November 29, 2010 - 8:58 AM EST)
News by QuoteMedia
www.quotemedia.com
Black Hawk Exploration acquires oil and gas leases in Cowley County, Kansas
Nov. 29, 2010 (M2 Communications Ltd.) --
Metals and energy exploration company Black Hawk Exploration (OTCBB:BHWX.ob) reported on Monday that it has purchased oil and gas leases covering approximately 2,553 acres of land in Cowley County, Kansas.
Black Hawk said that it owns 100% of the leases within the Prospect Area and has an undivided 81.5% working interest in and to the oil and gas leases and their previous 10 shut-in oil and gas wells.
The lease acquisition includes a 100% interest in one shut-in oil/gas well, the #1 Baker, located on the Keith Baker lease, as well as a 100% interest in nine other oil wells that were previously shut- in.
Under Black Hawk's Oil 2011 Program the company plans to re-work all 10 locations directly or in joint venture with Tiger Oil and Energy Inc (OTCBB:TGRO.ob) and return all of them to cash flow production.
In a separate agreement Tiger Oil & Gas LLC, a Kansas limited liability company, has agreed to operate and participate in the development and exploration of additional oil and gas leases on behalf of Black Hawk.
(Comments on this story may be sent to info@m2.com)
Source: M2 Presswire (November 29, 2010 - 8:55 AM EST)
News by QuoteMedia
www.quotemedia.com
Intelbahn Inc./UnionTown Energy Explores Opportunities in Rich Heath Plays in Montana
Shale Oil and Gas an Increasingly Important Source of Natural Gas in the United States
Nov. 29, 2010 (Marketwire) --
LAS VEGAS, NV -- (Marketwire) -- 11/29/10 -- Intelbahn Inc./UnionTown Energy Inc. (OTCBB: INBH), an Independent Oil & Gas Company, today announced that it has commenced its review of key projects provided by outside oil and energy advisors in potential opportunities including those in the in the newly developing Heath Formation in Montana.
The Heath Shale Formation in Montana is a shale formation characterized by high oil content, porosity and significant fracturing. And The State of Montana recently issued drilling permits to several operators to explore for oil in fractured Mississippian Heath shale in the Central Montana Trough, with the main areas of interest for horizontal drilling being in Garfield, Petroleum, Fergus, Musselshell, and Rosebud counties.
UnionTown is now assessing a number of leasehold properties that may hold potential for oil and gas production made possible by new technologies that have made the drilling for oil and natural gas much easier with a great potential for payoff.
Shale gas recover technologies were recently featured on CBS' "60 Minutes." During the segment, Aubrey McClendon, the CEO of Chesapeake Energy, was quoted as saying, "In the last few years, we've discovered the equivalent of two Saudi Arabias of oil in the form of natural gas in the United States. Not one, but two."
UnionTown Energy
UnionTown Energy Inc. is an Independent Oil & Gas Company whose focus is on the acquisition, development and production of oil and natural gas properties. The Company is pursuing a strategy of building a portfolio of energy producing assets that include coal bed methane, natural gas, shale gas, oil sands and deep natural gas throughout Western Canada and the United States. The Company's flagship property is located in Kansas within the Cherokee basin, which has been producing gas from shale and coal deposits for over eighty years and has 2.8 Tcf of potential recoverable CBM. Please visit www.uniontownenergy.com
Safe Harbor
The information in this release includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Although the company believes that its expectations are based on reasonable assumptions, actual results may differ materially. These forward-looking statements involve risks and uncertainties that include, among others, fluctuations in natural gas and crude oil prices; the timely receipt of necessary permits and approvals; market demand for, and/or available supplies of, energy-related products and services; unanticipated project delays, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, commercial agreements, acquisitions and strategic transactions, government regulation and taxation. More information about factors that potentially could affect the Company's financial results is included in its filings with the Securities and Exchange Commission.
Contact:
Patrick Smyth
(702) 530-3241
Email Contact
Source: Marketwire (November 29, 2010 - 8:50 AM EST)
News by QuoteMedia
www.quotemedia.com
China Pediatric Pharmaceuticals Reports Third Quarter 2010 Financial Results
Nov. 29, 2010 (Business Wire) -- China Pediatric Pharmaceuticals, Inc. (OTC Bulletin Board: CPDU) ("China Pediatric Pharmaceuticals" or the "Company"), today announced its financial results for the third quarter ended September 30, 2010. The Company's quarterly report on Form 10-Q was filed with the U.S. Securities Exchange Commission on November 22, 2010.
“We are very pleased with our third quarter results. Our sales and profit increased significantly, and we expect to continue increasing sales by expanding our market reach and strengthening our brand recognition. Our product lines are becoming increasingly visible in pharmacies throughout many regions in China,” stated Mr. Jun Xia, Chairman and Chief Executive Officer of China Pediatric Pharmaceuticals.
Third Quarter 2010 Highlights
Net sales increased by $3,002,538, or 72%, year-over-year, to $7,182,906. Within these, net sales from Cooer Series reached approximately $5.8 million.
Gross profit increased by $1,639,370, or 63%, year-over-year, to $4,229,885.
Net income increased by $109,553, or 11%, year-over-year, to $1,107,146.
Non-GAAP net income increased by $849,553 or a 85% year-over-year increase to $1,847,146 after adjusting for the non-cash share-based derivative expense of approximately $740,000.
Earnings per share in the 3 months ended September 30, 2010 decreased by $0.01, or 8% year-over-year, to $0.11.
Non-GAAP earnings per share increased by $0.06, or 5% year-over-year, to $0.18.
Financial Review for Third Quarter Ended September 30, 2010
During the three and nine months ended September 30, 2010, total net sales increased by approximately $3 million or 72% and $9.1 million or 80%, respectively, compared to the comparable periods in 2009.
A significant portion of the increase in sales is derived from an increase in sales for the "Cooer" Series by $2.6 million or 80% and $8.7 million or 104% in the three and nine months ended September 30, 2010, respectively. This was mainly due to the increase in sales volume as demand from customers increased as well as a result of the intensive promotion in 2010.
Gross profit increased about $1.6 million or 63% and $5 million or 72% in the three and nine months ended September 30, 2010, respectively, compared to the same periods of 2009. The increase in gross profit was due primarily to the increase in net sales of "Cooer" Series that was achieved through an expansion of the customer base, as mentioned above. The overall gross profit margin decreased 3%and 2% in the three and nine months ended September 30, 2010, respectively, compared to the comparable periods in 2009.
For the three months ended September 30, 2010, the slight decrease in overall gross profit margin was primarily due to the increase in cost of sales offset against a slight increase in the sales price of finished goods. Cost of sales increased mainly due to the increase in average unit cost of finished goods, as direct labor costs increased following the increase in statutory minimum wages in the PRC. The slight increase in sales prices of finished goods were due to inflation and increase in cost of sales.
As a result of GMP inspection, production was temporarily suspended in the first quarter of 2010 and as a result we experienced a surplus in raw materials on hand for production. To adjust for this, the Company sold all the surplus raw materials with carrying value amounting to US$645,682 (i.e. at cost US$1,136,898 net of impairment brought forward US$491,216) included in “Others” back to its suppliers at US$982,894 (i.e. at a discount around 86% of the original costs US$1,136,898). Consequently, the overall gross profit ratio slightly decreased for the first nine months of 2010 compared with the same period in 2009.
As a result of the above, in the three months ended September 30, 2010, net income in the three months ended September 30, 2010, increased by $109,553, or11%, year-over-year to $1,107,146, and earnings per share decreased by $0.01, or 8%, to $0.11, year-over-year.
Non-GAAP net income for the third quarter of FY2010 was $1,847,146, an approximately 85% increase from non-GAAP net income of $997,593 for the same quarter in FY2009. Non-GAAP net income for the third quarter of FY2010 was derived after adjusting for the aforementioned non-cash share-based Derivative expense of approximately $740,000, as a result of stock options granted to the shell shareholders together with the RTO. Non-GAAP earnings for the quarter ended September 30, 2010, were $0.18 per diluted share, compared to $0.12 per diluted share, for the quarter ended September 30, 2009. Please see the table below for a reconciliation of GAAP financial information to non-GAAP financial information.
GAAP to Non-GAAP Reconciliation Table (unaudited)
(in U.S. Dollars)
Three Months Ended September 30
2010 2009
GAAP - Net income $ 1,107,146 $ 997,593
Add back / (Subtract): 740,000
Non-cash Stock Based Compensation 740,000 -
Non-GAAP Net Income $ 1,847,146 $ 997,593
GAAP Earnings (loss) per share (diluted) $ 0.11 $ 0.12
Non-GAAP Earnings per share (diluted) $ 0.18 $ 0.12
In the nine months ended September 30, 2010, the net income increased by $1,210,899 or 47% to $3,794,291, year-over-year, and earnings per share increased by $0.09 or 29% to $0.40, year-over-year.
Non-GAAP net income for the nine months ended September 30, 2010, was $5,055,541, increased by $2,472,149 or an approximately 96% increase from non-GAAP net income of $2,583,392 for the same period in 2009. Non-GAAP net income for the third quarter of FY2010 was derived after adjusting for the aforementioned non-cash share-based derivative expense of $1,261,250, as a result of stock options granted to the shell shareholders together with the RTO. Non-GAAP earnings for the nine months ended September 30, 2010, were $0.54 per diluted share, compared to $0.31 per diluted share, for the quarter ended September 30, 2009. Please see the table below for a reconciliation of GAAP financial information to non-GAAP financial information.
GAAP to Non-GAAP Reconciliation Table (unaudited)
(in U.S. Dollars)
Nine Months Ended September 30
2010 2009
GAAP - Net income $ 3,794,291 $ 2,583,392
Add back / (Subtract): 1,261,250
Non-cash Stock Based Compensation 1,261,250 -
Non-GAAP Net Income $ 5,055,541 $ 2,583,392
GAAP Earnings (loss) per share (diluted) $ 0.40 $ 0.31
Non-GAAP Earnings per share (diluted) $ 0.54 $ 0.31
Non GAAP Financial Measures
To supplement the Company's consolidated financial statements for the three months and nine months ended September 30, 2010 and 2009 presented on a GAAP basis, the Company provided non-GAAP financial information in this release that excludes the impact of non-cash charges share-based derivative expense related to the stock options granted to the shell shareholders together with the RTO. The Company's management believes that these non-GAAP measures, namely non-GAAP net income and non-GAAP diluted earnings per share, provide investors with a better understanding of how the results relate to the Company's current and historical performance. The additional non-GAAP information is not meant to be considered in isolation or as a substitute for GAAP financials. The non-GAAP financial information that the Company provides also may differ from the non-GAAP information provided by other companies. Management believes that these non-GAAP financial measures are useful to investors because they exclude non-cash expenses that management excludes when it internally evaluates the performance of the Company's business and makes operating decisions, including internal budgeting, and performance measurement, because these measures provide a consistent method of comparison to historical periods. Moreover, management believes that these non-GAAP measures reflect the essential operating activities of the Company. In addition, the provision of these non-GAAP measures allows investors to evaluate the Company's performance using the same methodology and information as that used by the Company's management. Non-GAAP measures are subject to inherent limitations because they do not include all of the expenses included under GAAP and because they involve the exercise of judgment of which charges are excluded from the non-GAAP financial measure. However, the Company's management compensates for these limitations by providing the relevant disclosure of the items excluded.
About China Pediatric Pharmaceuticals, Inc.
China Pediatric Pharmaceuticals, Inc. has its headquarters in Xi’an, Shaanxi Province, China. The Company identifies, discovers, develops manufactures and distributes both prescription and over-the counter, including both conventional and Traditional Chinese Medicines (“TCMs”), pharmaceutical products for the treatment of some of the most common ailments and diseases, with pediatric medicine as its focus. The Company’s manufacturing facility located in Baoji City, Shaanxi Province. The Company distributes its high value, branded medicines, both prescription and OTC, through exclusive territory agents who sell our products directly to local pharmacies who in turn sell them to their retail customers. For the nine months ended September 30, 2010,Revenue was $20,400,566 and Net Income was $3,794,291 or $0.40 per share. As at September 30, 2010, Shareholders’ Equity was $15,385,239 and Total Assets were $27,254,954. For more information see our website at www.chinapediatricpharma.com.
Safe Harbor Statement
This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the company's ability to raise additional capital to finance the company's activities; the effectiveness, profitability, and the marketability of its products; legal and regulatory risks associated with the share exchange; the future trading of the common stock of the company; the ability of the company to operate as a public company; the period of time for which its current liquidity will enable the company to fund its operations; the company's ability to protect its proprietary information; general economic and business conditions; the volatility of the company's operating results and financial condition; the company's ability to attract or retain qualified senior management personnel and research and development staff; and other risks detailed in the company's filings with the Securities and Exchange Commission and available on its website at http://www.sec.gov. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the companies and the industry. The company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law. Although the company believes that the expectations expressed in these forward looking statements are reasonable, they cannot assure you that their expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.
China Pediatric Pharmaceuticals, Inc.
Mr. Jun Xia, Chief Executive Officer
Mr. Minggang Xiao, Chief Financial Officer
Ms. Angel Feng, Vice President, Corporate Affairs
9th Floor, No. 29 Nanxin Street, Xi’an, Shaanxi Province, P.R.C., 710004
Phone: 86-29-8727-1818
E-mail: ir@chinapediatricpharma.com
Source: Business Wire (November 29, 2010 - 8:45 AM EST)
News by QuoteMedia
www.quotemedia.com
Nature's Call Announces That Robert Van Egmond Has Joined the Company's Advisory Board
Nov. 29, 2010 (Business Wire) -- Nature’s Call Brands Inc. (OTCBB:NATC) (“Nature’s Call” or the “Company”) is pleased to announce that Robert Van Egmond, P.Geo, has agreed to join the Company’s advisory board.
Mr. Van Egmond’s professional career encompasses a wide spectrum of experience and successes ranging from project generation to pre-feasibility level resource development. Over the past twenty years he has worked for various major mining companies including Teck-Cominco, BHP and Kennecott as well as exploration companies in base metals, precious metals and diamond exploration in both North and South America. In recent years he has been working on the development of the 1 billion tonne Canariaco copper porphyry resource in northern Peru bringing it from initial exploration drilling through to mineral resource development drilling and mine engineering stages. As Exploration Manager for Candente Resource Corp. in Peru, he assessed properties for the company’s portfolio, assisted in the negotiation of joint venture transactions and coordinated several target drill stage programs. Currently, he will be performing property assessments, qualifying reports and mineral resource development.
“The addition of Rob Van Egmond to our advisory board is another important step in Nature’s Call vision to strengthen our precious metals mining expertise”, stated Robbie Manis, Chief Executive Officer. “Rob’s proven business and mining acumen will be vital in transitioning our company towards becoming an established mineral producer. His fluency with the Spanish language will also represent a significant asset for the Company as it moves to further its gold and silver mining initiatives within Mexico.”
About Nature’s Call Brands Inc.
Nature’s Call is based in Las Vegas, Nevada and trades on the OTC Bulletin Board under the trading symbol “NATC”. The Company is focused on the acquisition and exploration of international gold and silver mining properties located in regions that enjoy stable politics, sound economies and friendly business environments. Additional information about the Company may be found at www.naturescall.com.
Forward Looking Statements
This news release contains forward-looking statements. Forward looking statements in this news release include assertions regarding the contributions to be made to the Company by the incoming advisor. There can be no certainty regarding the benefits to be realized by the Company as a result of this appointment. Accordingly, should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements. As a result, readers are advised not to place undue reliance on forward-looking statements or information. The Company does not undertake any obligation to release publicly revisions to any “forward-looking statement,” to reflect events or circumstances after the date of this news release, or to reflect the occurrence of unanticipated events, except as is required under applicable securities laws.
Nature’s Call Brands Inc.
Robbie Manis, 702-509-5049
Chief Executive Officer
info@naturescall.com
Source: Business Wire (November 29, 2010 - 8:42 AM EST)
News by QuoteMedia
www.quotemedia.com
DTC Approves VIASPACE Green Energy Shares for Electronic Trading on the OTC Bulletin Board
Allows Shareholders to Buy and Sell VGREF Stock Electronically through Brokers
Nov. 29, 2010 (PR Newswire) --
IRVINE, Calif., Nov. 29, 2010 /PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC), announced that its renewable energy subsidiary, VIASPACE Green Energy Inc. (OTC Bulletin Board: VGREF) has been granted eligibility status by the Depository Trust Company (DTC), which allows shares to be bought and sold with rapid electronic clearing. The Securities and Exchange Commission (SEC) and Financial Industry Regulatory Authority (FINRA) had previously granted their approval for trading.
The DTC provides the electronic basis through which stock sales bought and sold through brokers are transferred from the seller's brokerage account to the buyer's account.
Chief Executive Dr. Carl Kukkonen commented, "DTC eligibility allows simple low cost electronic transactions to trade VIASPACE Green Energy shares. This is an important step in increasing our shareholder base and a significant milestone for the Company."
VIASPACE Green Energy is a majority owned (75.7%) subsidiary of VIASPACE Inc. Both companies are publicly listed on the OTC Bulletin Board. VIASPACE (VSPC) has been listed and fully reporting to the SEC since June 2005. VIASPACE Green Energy (VGREF) has been listed and reporting since January 2010, and the company has now received approval of electronic clearing by the DTC. VIASPACE Green Energy has 8,600,000 shares issued and outstanding.
Information on VIASPACE Green Energy and its dedicated energy crop, Giant King Grass, is available at www.viaspacegreenenergy.com or www.vgref.com or www.VIASPACE.com.
About VIASPACE Inc.
VIASPACE is a clean energy company providing products and technology for renewable and alternative energy that reduce or eliminate dependence on fossil and high-pollutant energy sources. Through its majority-owned subsidiary VIASPACE Green Energy Inc., the Company grows Giant King Grass as a low-carbon fuel for electricity generating power plants, as a feedstock for bio methane production and cellulosic biofuels, and for other low-carbon, renewable energy products. VIASPACE recently introduced its Green Log™ fireplace and campfire log product. For more information, please go to www.viaspace.com or contact Dr. Jan Vandersande, Director of Communications, at 800-517-8050 or IR@VIASPACE.com.
Safe Harbor Statement
Information in this news release includes forward-looking statements. These forward-looking statements relate to future events or future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Such factors include, without limitation, risks outlined in our periodic filings with the U.S. Securities and Exchange Commission, including Annual Report on Form 10-K for the year ended December 31, 2009, as well as general economic and business conditions; the ability to acquire and develop specific products and technologies; changes in consumer and business demand for the Company's products; competition from larger companies; changes in demand for alternative and clean energy; risks associated with international transactions; risks related to technological change; and other factors over which VIASPACE has little or no control.
SOURCE VIASPACE Inc.
Source: PR Newswire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Blue Earth to Grant Special One-Time Dividend, an 'A Warrant', to Its December 31st, 2010 Shareholders of Record
November 17th Shareholder Conference Call Available at www.blueearthinc.com
Nov. 29, 2010 (PR Newswire) --
HENDERSON, Nev., Nov. 29, 2010 /PRNewswire-FirstCall/ -- Blue Earth, Inc. (OTC Bulletin Board: BBLU), announced today it will grant a special one-time dividend to its December 31, 2010 shareholders of record. This special dividend will be one A Warrant for every two shares held on December 31, 2010 and is exercisable at $3 per share for a three year term.
Additionally, for those shareholders eligible for A Warrants, for every A Warrant exercised, they will then receive a share of Common Stock and a special B Warrant, which has an exercise price of $6 per share for a new three year term. For every B Warrant exercised, they will receive a share of Common Stock and a C Warrant, with an exercise price of $12 per share for a new three year term.
On Wednesday, November 17, 2010, Blue Earth, Inc. held a shareholder conference call that can be heard on its website at www.blueearthinc.com. CEO Dr. Johnny R. Thomas discussed in detail the reasoning behind the recent changes that have occurred as well as the conclusions that led the Company to expand its business strategy.
"Our immediate focus in the energy efficiency 'retrofit' sector is the result of extensive analysis. We thank those who attended our conference call and encourage everyone to follow the Company for future announcements," said Dr. Thomas.
About BBLU
BBLU is engaged in the clean technology industry with a primary focus on the energy efficiency and water and wastewater sectors. We strive to participate in the global movement for a sustainable planet by offering products and services that optimize energy use, reduce harmful environmental emissions and substantially reduce energy costs to our customers. For more information about Blue Earth, Inc., please visit www.blueearthinc.com.
Investor Relations Contact:
Blue Earth, Inc.
John C. Francis
VP, Corporate Development & Investor Relations
(702) 630-2345
jfrancis@blueearthinc.com
Liviakis Financial Communications, Inc.
John Liviakis
(415)-389-4670
John@Liviakis.com
www.liviakis.com
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements.
Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
SOURCE Blue Earth, Inc.
Source: PR Newswire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Weikang Bio-Technology Issues Fiscal 2011 Revenue Guidance of $71 - $82 Million and Net Profit of $27 - $31 million or $0.97 - $1.12 Earnings per Share
Nov. 29, 2010 (PR Newswire) --
HARBIN, China, Nov. 29, 2010 /PRNewswire-Asia-FirstCall/ -- Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) ("Weikang" or the "Company"), a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.
"We are working extremely diligent to enhance our market penetration as we continue to build a high-quality therapeutics company. We have launched several new therapeutics this year and have plans to launch several more new therapeutics in 2011. In addition, we have expanded our sales coverage area by adding three new distributors," commented Mr. Yin Wang, Chairman and CEO of Weikang Bio-Technology Group. "Therefore, we believe that we have created a solid foundation to continue expanding sales, increase revenue and net income and strengthen shareholder value."
About Weikang Bio-Technology Group Co., Inc.
Weikang Bio-Technology Group Co., Inc. is principally engaged in developing, manufacturing and distributing Traditional Chinese Medicine (TCM), and health and nutritional supplements in China, in compliance with requisite Chinese licenses and approvals. The Company is also expanding its business scope to develop, manufacture and distribute Chinese herbal extract products and GMP certified western prescription and OTC pharmaceuticals through its acquisition of Tianfang. For more information, please visit http://www.weikangbio.com.
Safe Harbor Statement
This press release contains certain statements that may include "forward looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
Investors Relation contacts:
John Marco, Partner, Elite IR
Tel: +1-310-819-2948
Email: John.marco@elite-ir.com
Leslie J. Richardson, Partner, Elite IR
Tel: +852-3183-0283
Email: Leslie.richardson@elite-ir.com
SOURCE Weikang Bio-Technology Group Co., Inc.
Source: PR Newswire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Mymetics Secures New Patent for Virosome Based Vaccines
Nov. 29, 2010 (Marketwire) --
EPALINGES, SWITZERLAND -- (Marketwire) -- 11/29/10 -- Mymetics Corporation (OTCBB: MYMX), a pioneer in the development of vaccines preventing early transmission of human infectious diseases, announced today that the United States Patent and Trademark Office has issued a notice of allowance for the patent application "Phospholipid Virosome" # 10/544,939, based on WO 04/071492.
Dr. Toon Stegmann, CSO of Mymetics BV, said, "This patent not only allows Mymetics to use a production method that results in better yields and provides an increased activity of virosome vaccines, but it also allows Mymetics to develop virosome based vaccines on any other enveloped virus than flu."
Jacques-François Martin, CEO of Mymetics, added "This patent complements very well the intellectual property portfolio around Mymetics' vaccine pipeline and broadens, in particular, our technology platform to develop other non-influenza virosome based vaccines. It is also an additional confirmation of the importance of our acquisition of Virosome Biologicals last year."
Mymetics already uses this new innovative production method for its Respiratory Syncytial Virus (RSV) and Herpes Simplex Virus (HSV) vaccine that are in preclinical development.
The patent, which describes a method for the production of virosome vaccines based on a short-chain phospholipid, was developed by Mymetics BV in collaboration with the University of Groningen, in the Netherlands. Mymetics BV was formerly known as Virosome Biologicals, which was acquired by Mymetics Corporation in April 2009.
Since the opposition period for the European equivalent of the patent ended at the same time, without opposition being filed, and considering that patent was also granted in most Asian countries, the key technology that will be the basis for Mymetics' future vaccines is now secure.
About Virosomes
A virosome is a drug or vaccine delivery mechanism consisting of a lipid membrane based on an enveloped virus. This membrane can incorporate virus derived proteins to allow the virosomes to fuse with target cells or it can be used as the full natural membrane and proteins of the virus to develop an appropriate vaccine. Virosomes are not able to replicate but are pure fusion-active vesicles. The safety and efficacy of the original virosome technology, which is based on the influenza envelope, has been approved in more than 40 countries for two vaccines developed and marketed by Crucell, one for influenza and one for Hepatitis A.
About Mymetics
Mymetics Corporation is a Swiss-based biotechnology company registered in the US (OTC BB: MYMX) developing next-generation preventative vaccines for infectious diseases. Mymetics' core technology and expertise are based on the use of virosomes, lipid-based carriers containing functional fusion viral proteins, in combination with rationally designed antigens. The company's vaccines are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, which for some pathogens may be essential for the development of an effective vaccine. Mymetics is led by an international and experienced management team and is supported by a strong Scientific Advisory Board composed of renowned experts. The company has established contacts with world leaders in vaccine development.
Mymetics currently has 5 vaccines in its pipeline: HIV-1/AIDS, Influenza, Respiratory Syncytial Virus, Malaria and Herpes Simplex Virus. The company's HIV vaccine is entering a new proof-of-concept preclinical trial following unprecedented results in a first study, and is also currently in a Phase I clinical trial in human volunteers. A Phase 1b clinical trial for its Malaria vaccine on children in Tanzania has been completed, while RSV and HSV vaccine candidates are in the preclinical phase. The Influenza vaccine has been out-licensed to Solvay Pharmaceuticals (now Abbott). For further information, please visit www.mymetics.com.
Forward looking statements
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements, which are identified by the words "believe," "expect," "anticipate," "intend," "plan" and similar expressions. The statements contained herein which are not based on historical facts are forward-looking statements that involve known and unknown risks and uncertainties that could significantly affect our actual results, performance or achievements in the future and, accordingly, such actual results, performance or achievements may materially differ from those expressed or implied in any forward-looking statements made by or on our behalf. These risks and uncertainties include, but are not limited to, risks associated with our ability to successfully develop and protect our intellectual property, our ability to raise additional capital to fund future operations and compliance with applicable laws and changes in such laws and the administration of such laws. See Mymetics' most recent Form 10-K for a discussion of such risks, uncertainties and other factors. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date the statements were made.
Contact:
Ronald Kempers
CFO and COO
Mymetics Corporation
Tel: +41 21 653 4535
U.S. Media:
Michelle Linn
Linnden Communications
Tel: 508-362-3087
Email: Email Contact
Europe Media:
Christophe Lamps
Senior Partner
Dynamics Group
Mobile: + 41 79 476 26 87
Email: Email Contact
Source: Marketwire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Mymetics Secures New Patent for Virosome Based Vaccines
Nov. 29, 2010 (Marketwire) --
EPALINGES, SWITZERLAND -- (Marketwire) -- 11/29/10 -- Mymetics Corporation (OTCBB: MYMX), a pioneer in the development of vaccines preventing early transmission of human infectious diseases, announced today that the United States Patent and Trademark Office has issued a notice of allowance for the patent application "Phospholipid Virosome" # 10/544,939, based on WO 04/071492.
Dr. Toon Stegmann, CSO of Mymetics BV, said, "This patent not only allows Mymetics to use a production method that results in better yields and provides an increased activity of virosome vaccines, but it also allows Mymetics to develop virosome based vaccines on any other enveloped virus than flu."
Jacques-François Martin, CEO of Mymetics, added "This patent complements very well the intellectual property portfolio around Mymetics' vaccine pipeline and broadens, in particular, our technology platform to develop other non-influenza virosome based vaccines. It is also an additional confirmation of the importance of our acquisition of Virosome Biologicals last year."
Mymetics already uses this new innovative production method for its Respiratory Syncytial Virus (RSV) and Herpes Simplex Virus (HSV) vaccine that are in preclinical development.
The patent, which describes a method for the production of virosome vaccines based on a short-chain phospholipid, was developed by Mymetics BV in collaboration with the University of Groningen, in the Netherlands. Mymetics BV was formerly known as Virosome Biologicals, which was acquired by Mymetics Corporation in April 2009.
Since the opposition period for the European equivalent of the patent ended at the same time, without opposition being filed, and considering that patent was also granted in most Asian countries, the key technology that will be the basis for Mymetics' future vaccines is now secure.
About Virosomes
A virosome is a drug or vaccine delivery mechanism consisting of a lipid membrane based on an enveloped virus. This membrane can incorporate virus derived proteins to allow the virosomes to fuse with target cells or it can be used as the full natural membrane and proteins of the virus to develop an appropriate vaccine. Virosomes are not able to replicate but are pure fusion-active vesicles. The safety and efficacy of the original virosome technology, which is based on the influenza envelope, has been approved in more than 40 countries for two vaccines developed and marketed by Crucell, one for influenza and one for Hepatitis A.
About Mymetics
Mymetics Corporation is a Swiss-based biotechnology company registered in the US (OTC BB: MYMX) developing next-generation preventative vaccines for infectious diseases. Mymetics' core technology and expertise are based on the use of virosomes, lipid-based carriers containing functional fusion viral proteins, in combination with rationally designed antigens. The company's vaccines are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, which for some pathogens may be essential for the development of an effective vaccine. Mymetics is led by an international and experienced management team and is supported by a strong Scientific Advisory Board composed of renowned experts. The company has established contacts with world leaders in vaccine development.
Mymetics currently has 5 vaccines in its pipeline: HIV-1/AIDS, Influenza, Respiratory Syncytial Virus, Malaria and Herpes Simplex Virus. The company's HIV vaccine is entering a new proof-of-concept preclinical trial following unprecedented results in a first study, and is also currently in a Phase I clinical trial in human volunteers. A Phase 1b clinical trial for its Malaria vaccine on children in Tanzania has been completed, while RSV and HSV vaccine candidates are in the preclinical phase. The Influenza vaccine has been out-licensed to Solvay Pharmaceuticals (now Abbott). For further information, please visit www.mymetics.com.
Forward looking statements
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements, which are identified by the words "believe," "expect," "anticipate," "intend," "plan" and similar expressions. The statements contained herein which are not based on historical facts are forward-looking statements that involve known and unknown risks and uncertainties that could significantly affect our actual results, performance or achievements in the future and, accordingly, such actual results, performance or achievements may materially differ from those expressed or implied in any forward-looking statements made by or on our behalf. These risks and uncertainties include, but are not limited to, risks associated with our ability to successfully develop and protect our intellectual property, our ability to raise additional capital to fund future operations and compliance with applicable laws and changes in such laws and the administration of such laws. See Mymetics' most recent Form 10-K for a discussion of such risks, uncertainties and other factors. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date the statements were made.
Contact:
Ronald Kempers
CFO and COO
Mymetics Corporation
Tel: +41 21 653 4535
U.S. Media:
Michelle Linn
Linnden Communications
Tel: 508-362-3087
Email: Email Contact
Europe Media:
Christophe Lamps
Senior Partner
Dynamics Group
Mobile: + 41 79 476 26 87
Email: Email Contact
Source: Marketwire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
TV Goods to Launch National Marketing Campaign for Nasal SoftStrips(TM)
Nasal SoftStrips(TM) Use 100 Percent Natural FDA Market-Approved Essential Oils and Vapors That Are Known to Have Health Benefits
Nov. 29, 2010 (Marketwire) --
CLEARWATER, FL -- (Marketwire) -- 11/29/10 -- TV Goods Holding Corporation ("TV Goods"), a direct response marketing organization and wholly owned subsidiary of H & H Imports, Inc. (OTCBB: HNHI), announced it has acquired exclusive marketing rights to Nasal SoftStrips™. Developed by doctors and medical professionals, Nasal SoftStrips™ are a revolutionary new product approved by the FDA to manage and improve your health and wellness.
Nasal SoftStrips™ are designed to deliver therapeutic blends of essential oils to provide simple, safe and effective solutions to manage and improve your health and wellness. Scientific studies have proven certain scents can help to control appetite, promote relaxation, control nausea, and assist with smoking cessation among other things. Nasal SoftStrips™ are small strips that bend comfortably to the septum of the nose. For more information, please visit www.nasalsoftstrips.com.
TV Goods acquired global marketing rights for multiple distribution channels Nasal SoftStrips™. TV Goods will produce an infomercial spot geared toward the consumer market aimed to drive retails sales to big box and other national and local retailers.
"This is a great, simple, FDA-approved way to suppress appetite. We are excited to produce a spot for this and bring it to retail," said Steve Rogai, CEO of TV Goods Holding Corporation.
About The Company:
H & H Imports, Inc. is the parent company of TV Goods Holding Corporation. TV Goods Holding Corporation is a direct response marketing company. We identify, develop and market consumer products for global distribution. TV Goods was established by Kevin Harrington, a pioneer and principal architect of the "infomercial" industry. Kevin Harrington is an original investor on the ABC show Shark Tank, which is owned by SONY Pictures and produced by reality TV mogul Mark Burnett. TV Goods management is responsible for over 500 infomercial spots accounting for over $4 billion in sales revenues. For more information go to www.TVGoodsInc.com.
Forward-Looking Statements:
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
Contact:
TV Goods Holding Corporation
Kathryn Goodbread
kgoodbread@tvgoodsinc.com
727-474-0598
Source: Marketwire (November 29, 2010 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
PolyMedix to Present at the NYSSA Biotech and Specialty Pharmaceutical Conference
Nov. 29, 2010 (Business Wire) -- PolyMedix, Inc. (OTC BB: PYMX), a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, announced today that Nicholas Landekic, President & CEO of PolyMedix, will present at the New York Society of Security Analysts 14th Annual Biotech and Specialty Pharmaceutical Conference on Tuesday, November 30, 2010 at 1:35 p.m. Eastern Time.
A live webcast of Mr. Landekic’s presentation will be available at: http://investor.shareholder.com/media/eventdetail.cfm?eventid=86224&CompanyID=ABEA-4ITCYZ&e=1&mediaKey=AA30477493DD80F026CCF4C7874D5D89 or on the Company’s website at www.polymedix.com. A replay will be available on both sites for 90 days following the event.
About PolyMedix, Inc.
PolyMedix is a publicly traded biotechnology company focused on the development of novel drugs for the treatment of serious infectious diseases and acute cardiovascular disorders. PolyMedix uses a rational drug design approach to create non-peptide, small-molecule drug candidates. PolyMedix’s lead antibiotic compound, PMX-30063, is currently in Phase 2 clinical trials. PMX-30063 is a small-molecule that mimics the mechanism of action of human host defense proteins, a mechanism that is distinct from currently approved antibiotic drugs and is intended to make bacterial resistance unlikely to develop. PolyMedix plans to develop this compound for serious systemic Staphylococcal infections, including methicillin resistant Staphylococcus aureus (MRSA). PolyMedix’s lead heptagonist compound, PMX-60056, has completed Phase 1 testing and is being developed to reverse the anticoagulant activity of both heparin and low molecular weight heparins (LMWH). PolyMedix believes that PMX-60056 could potentially be a safer and easier to use anticoagulant reversing agent, with broader activity, than the currently approved therapy for reversing heparin and LMWH. In addition to its small molecule therapeutics, PolyMedix has polymeric formulations with the same mechanism of action as PMX-30063, PolyCides™. PolyCides are intended for use in antimicrobial biomaterials applications as additives to paints, plastics, and textiles to create self-sterilizing products and surfaces. For more information, please visit our website at www.polymedix.com.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause PolyMedix’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward looking statements. PolyMedix has in some cases identified forward-looking statements by using words such as “anticipates,” “believes,” “hopes,” “estimates,” “looks,” “expects,” “plans,” “intends,” “goal,” “potential,” “may,” “suggest,” and similar expressions. Among other factors that could cause actual results to differ materially from those expressed in forward-looking statements are PolyMedix’s need for, and the availability of, substantial capital in the future to fund its operations and research and development, and the fact that PolyMedix’s compounds may not successfully complete pre-clinical or clinical testing, or be granted regulatory approval to be sold and marketed in the United States or elsewhere. A more complete description of these risk factors is included in PolyMedix’s filings with the Securities and Exchange Commission. You should not place undue reliance on any forward-looking statements. PolyMedix undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
PolyMedix, Inc.
Lisa Caperelli, 484-598-2406
Director, Investor Relations & Corporate Communications
lcaperelli@polymedix.com
Source: Business Wire (November 29, 2010 - 8:27 AM EST)
News by QuoteMedia
www.quotemedia.com
Virginia Heritage Bank completes of private placement of 541,576 common shares at USD9.75 per share
Nov. 29, 2010 (M2 Communications Ltd.) --
(Comments on this story may be sent to tww.feedback@m2.com)
Source: M2 Presswire (November 29, 2010 - 12:28 PM EST)
News by QuoteMedia
www.quotemedia.com
Financial Stock News: SNPY & DFS
Nov. 29, 2010 (M2 Communications Ltd.) --
Boston, MA — Sino Payments, Inc. (OTCBB: SNPY); Discover Financial Services (NYSE: DFS)
—————————————————————————
Stock Profiler.US, LLC (www.stockprofiler.us) has launched the Small Cap Market Place (SCMP), which features the CEO Module. Don’t Miss Out on the New Small Cap Market Place Revolution - The First 100 Companies to Sign Up for a CEO Module will Receive up to Three (3) Months of FREE Market Awareness Services!
CEO’s - Please contact Eric Cousens (eric@kerryassociates.com), President/CEO of Kerry Associates, Inc. at (603) 365-8034 for more information.
Sign up for your FREE subscription: http://www.stockprofiler.us/Register
—————————————————————————
Company News: Sino Payments Corporate Development Update
HONG KONG, Nov 29, 2010 — Sino Payments, Inc. (www.sinopayments.com) (OTCBB: SNPY) recently announced that it has signed a Letter of Intent with existing partner Tap Group to setup a jointly owned Hong Kong company for the purpose of pooling Asia regional retailer card processing projects in which Tap Group already has existing customer relationships.
Sino Payments, Inc. closed at $0.0122 Friday, trading 55,000 shares.
About Sino Payments, Inc. (www.sinopayments.com)
Sino Payments is a US public company with offices in Hong Kong. In addition to providing stand alone worldwide ecommerce processing capability, Sino Payments’ proprietary IP transaction processing system (SinoPay GPP) is designed to convert transaction processing systems from old type dial up point of sale systems linked to sophisticated check out terminals to a modern seamless IP transaction process, reducing credit and debit card transaction processing times by half at checkout. Sino Payments focuses on providing IP credit and debit card processing services to large retail chains, including supermarket chains and large regional multinational retailers, in China and throughout Asia.
—————————————————————————
Company News: Discover Begins Rollout of Contactless Devices to Consumers
RIVERWOODS, Ill. Nov. 29, 2010 - Discover card today announced that it has begun issuing Discover® Zip® contactless credit cards and stickers, targeted at early adopters of its mobile technology.
Discover Financial Services closed at $18.42 Friday, trading 787,800 shares.
About Discover
Discover Financial Services (NYSE: DFS) is a direct banking and payment services company with one of the most recognized brands in U.S. financial services. Since its inception in 1986, the company has become one of the largest card issuers in the United States. The company operates the Discover card, America’s cash rewards pioneer, and offers personal and student loans, online savings accounts, certificates of deposit and money market accounts through its Discover Bank subsidiary. Its payment businesses consist of Discover Network, with millions of merchant and cash access locations; PULSE, one of the nation’s leading ATM/debit networks; and Diners Club International, a global payments network with acceptance in more than 185 countries and territories. For more information, visit www.discoverfinancial.com.
—————————————————————————
About TheWallStreetLeader.com
TheWallStreetLeader.com is part of Stock Profiler.US, LLC’s News Division. Stock Profiler welcomes investors to sign up at www.stockprofiler.us to subscribe to our FREE newsletter. Please follow our thread on www.twitter.com at StockProfilerUS
Call us at (603) 424-4420 or email info@stockprofiler.us
—————————————————————————
Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. To read the news in its entirety, go to the Leader in Market News, Stock Profiler.US, LLC (www.stockprofiler.us) click the Headline Tab, enter the ticker symbol and click the news link. The companies that are discussed in this opinion have not approved the statements made in this opinion.
This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Stock Profiler.US, LLC’s News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com, http://www.fastmoneytalk.com, http://www.markettelegraph.com, http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.
Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
To view full disclaimers and terms of use, go to http://stockprofiler.us/Disclaimer.
—————————————————————————
Keywords: Facebook, MySpace, Yahoo News, Google News, Bloomberg News, Finance, Funding, Stock Quote, Small Cap Stock, Penny Stocks, SNPY, SNPY stock, SNPY stock news, SNPY stock alerts, SNPY company news
(Comments on this story may be sent to tww.feedback@m2.com)
Source: M2 Presswire (November 29, 2010 - 12:10 PM EST)
News by QuoteMedia
www.quotemedia.com
Ensurge Announces an Agreement for Tailings Gold Recovery Project in Brazil
Nov. 29, 2010 (PR Newswire) --
SALT LAKE CITY, Nov. 29, 2010 /PRNewswire-FirstCall/ -- Ensurge, Inc. (OTC Bulletin Board: ESGI) announces the agreement with Rodui Transportes & Locaoes.
Ensurge, Inc. is pleased to announce that it has entered into an Agreement with Rodui Transportes & Locaoes of Pocone, Mato Grosso, Brazil. Under terms of the Agreement, Ensurge will begin an evaluation process that will determine the gold content and technological and economic feasibility of recovering gold from two tailings impoundments owned by Rodui.
The tailings impoundments, each located within a few kilometers of Pocone, Mato Grosso, Brazil, were created during a greater than twenty year period during which Evaldino Rodui, the company's principal, operated a gold mining operation. That mine and processing facility were shut down in 2008.
Under terms of the Agreement, Ensurge will conduct a preliminary assessment of the gold content of the tailings. That assessment was begun at the end of last week. The cost of the preliminary assessment is to be borne in its entirety by Ensurge.
If the preliminary assessment, which should be completed by the middle of December, proves positive by confirming significant gold content, Ensurge will then embark upon, and pay for a detailed drilling and assaying program and an Engineering Scoping Study to determine the optimal process by which to recover gold. The Engineering Scoping Study would likely be started in early January of 2011 and require 3-4 months to complete.
If, upon completion of the Engineering Scoping Study, technological and economic feasibility is demonstrated, Ensurge will, at its expense, construct a facility to recover gold from tailings. Ensurge and Rodui will share equally in the profit from operating the Tailings Gold Recovery Plant.
About Ensurge
Ensurge, Inc. is a Salt Lake City based mining company focused on development of gold mining opportunities in Brazil. The company's primary focus is to bring capital and technology to existing mining operations to recover gold from existing tailings ponds, improve recoveries of existing milling operations and improve mining operations in exchange for an interest in these operations.
Ensurge is a fully reporting company currently traded on the OTC Bulletin Board under the symbol ESGI.
Forward Looking Statements
This press release contains forward-looking statements regarding the future results and performance of Ensurge, Inc. including statements regarding revenue, growth and market development. These forward-looking statements involve risks and uncertainties and actual results could differ materially from those predicted in any such forward-looking statements. Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. The realization of any or all of these expectations is subject to a number of risks and uncertainties and it is possible that the assumptions made by management may not materialize. Statements in this press release may involve risks and uncertainties; actual results may differ from the forward-looking statements. Sentences or phrases that use such words as "believes," "anticipates," "plans," "may," "hopes," "can," "will," "expects," "is designed to," "with the intent," "potential" and others indicate forward-looking statements, but their absence does not mean that a statement is not forward-looking. The Company undertakes no obligation to publicly release any revisions to forward-looking statements.
SOURCE Ensurge, Inc.
Source: PR Newswire (November 29, 2010 - 12:09 PM EST)
News by QuoteMedia
www.quotemedia.com
Renaissance BioEnergy closes acquisition of mining claims in Arizona
Nov. 29, 2010 (M2 Communications Ltd.) --
Development stage renewable energy company Renaissance BioEnergy Inc (OTCBB:RENS) signed and closed an agreement on Friday to acquire a 100% interest in 15 unpatented lode mining claims and another 12.5% undivided interest in the 22 unpatented placer mining claims included in the Oatman Gold Project, it disclosed the same day.
The company agreed with Backyard Stuff Inc, Wind Power Energy International LLC and other sellers to acquire the sellers' interest in the unpatented mining claims in Mohave County, Arizona.
Further, Renaissance said that the unpatented lode claims include the "King Midas", "Argo" and "Oatman Southern" Mines.
Additionally, with this acquisition the company said its total interest in these 22 unpatented placer mining claims are 62.5% while it has a 100% interest in the 15 unpatented lode mining claims in the Oatman Gold Project.
(Comments on this story may be sent to info@m2.com)
Source: M2 Presswire (November 29, 2010 - 12:07 PM EST)
News by QuoteMedia
www.quotemedia.com
Artificial Life plans over 30 new titles for Android in 2011
Nov. 29, 2010 (M2 Communications Ltd.) --
Artificial Life Inc (OTCBB:ALIF), a provider of mobile content and technology for smartphones, today announced the planned expansion of its product portfolio onto the Android platform.
As well as porting from its current collection of iPhone titles Artificial Life is developing more than 30 new titles especially for Android.
The new titles will feature more business-oriented applications and Artificial Life is also placing more emphasis on the Chinese market, which is said to be the world's second largest Android market.
Plans for the launch on the Android platform include a series of titles from the company's games portfolio produced with partners who include BMW and Red Bull.
(Comments on this story may be sent to tww.feedback@m2.com)
Source: M2 Presswire (November 29, 2010 - 11:38 AM EST)
News by QuoteMedia
www.quotemedia.com
Beacon Signs Agreement With Premier Systems Integration Group
-- Agreement to Create Cross-Marketing Opportunities with Joint Fortune 1000 ITS Clients --
Nov. 29, 2010 (PR Newswire) --
LOUISVILLE, Ky., Nov. 29, 2010 /PRNewswire/ -- Beacon Enterprise Solutions Group, Inc. (OTC Bulletin Board: BEAC) (www.askbeacon.com) an emerging global leader in the design, implementation and management of high performance Information Technology Systems (ITS) infrastructure solutions, today announces a Master Marketing Agreement has been executed with Controlco Sustainable Solutions Group (CSSG) to pursue joint ITS infrastructure, sustainability and integrated systemsprojects with Government and Fortune 1000 commercial and industrial clients.
(Logo: http://photos.prnewswire.com/prnh/20101021/DA85933LOGO)
The Master Marketing agreement will focus the two companies' sales and marketing efforts on clients with requirements for information technology and telecommunications products and services including software development, infrastructure design, passive optical networks, building systems integration and management platforms. This agreement will also enable Beacon to offer its own Smart Enterprise line of software products, which is a single, unified environment that brings together all aspects of implementing a successful ITS deployment and includes engineering components, user management, navigation building, data modeling, and dashboard design specific to the user responsibilities.
"This agreement creates two new strategic opportunities for Beacon," said Bruce Widener, CEO of Beacon Solutions. "First, Beacon will engage a new base of potential customers for ITS infrastructure services. This is the second Marketing Agreement in the last couple of months we have executed and I am proud to partner with another global leader of information technologies for cross-marketing opportunities. Second, the Beacon Smart Enterprise software will enable multi-location, or large clients, a centralized ITS management solution, which creates efficiency and operating savings. This relationship is highly complementary to each company's strengths and will enable us both to enter new client territory for organic growth. These new partnering opportunities allow Beacon to deliver more services our complex clients require, but at the same time keeping Beacon focused to our four core ITS disciplines we have identified as being the most profitable."
Founded in 1958, privately-held, California based CSSG is a division of Controlco, a premier systems integration and software developer for a broad spectrum of industrial and commercial clients. Controlco offers a full suite of products and services for building automation, industrial instrumentation, systems integration and software to suit customer needs with the highest quality and value to clients.
"I look forward to working with Beacon on solving the complex ITS infrastructure solutions our clients require," said Brian Turner, Vice President of Sales for Controlco. "Our Marketing Agreement will allow Beacon and Controlco to partner on ITS solutions for our joint clients, but also open a new client base to our respective companies and bring new solutions to both sales groups. The Controlco and Beacon ITS partnering solution will deliver a richer client experience for Fortune 1000 clients with the need to standardize, automate and better manage their ITS infrastructure."
About Beacon Enterprise Solutions Group, Inc.
Beacon Enterprise Solutions Group is an emerging global leader in the design, implementation and management of high performance Information Technology Systems ("ITS") infrastructure solutions. Beacon offers fully integrated, turnkey IT infrastructure solutions capable of fully servicing the largest companies in the world as they increasingly outsource to reduce costs while optimizing critical IT design and infrastructure management. Through an integrated team approach, Beacon offers a broad range of products and services including IT infrastructure design, implementation and management, application development and voice/data/security system integration, installation and maintenance. Beacon's client roster includes state and local agencies, educational institutions, and over 4,000 companies ranging in size from mid-sized companies to the Fortune 500. Beacon is headquartered in Louisville, Kentucky, with a regional headquarters in Dublin, Ireland, Prague, Czech Republic and personnel located throughout the United States and Europe.
For additional information, please visit Beacon's corporate website: www.askbeacon.com
This press release may contain "forward looking statements." Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements may include, without limitation, statements about our market opportunity, strategies, competition, expected activities and expenditures as we pursue our business plan. Although we believe that the expectations reflected in any forward looking statements are reasonable, we cannot predict the effect that market conditions, customer acceptance of products, regulatory issues, competitive factors, or other business circumstances and factors described in our filings with the Securities and Exchange Commission may have on our results. The company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.
Contact:
Bruce Widener, CEO
502-657-3507
investors@askbeacon.com
Porter, LeVay & Rose, Inc.
Marlon Nurse, V.P. – Investor Relations
212-564-4700
Halliburton Investor Relations
Geralyn DeBusk, President, or Hala Elsherbini, COO
972-458-8000
SOURCE Beacon Enterprise Solutions Group, Inc.
Source: PR Newswire (November 29, 2010 - 11:33 AM EST)
News by QuoteMedia
www.quotemedia.com
HQ Global Education Announces Conference Call to Discuss Fiscal Year 2010 Financial Results
Nov. 29, 2010 (GlobeNewswire) --
CHANGSHA CITY, China, Nov. 29, 2010 (GLOBE NEWSWIRE) -- HQ Global Education Inc. ("HQ" or the "Company") (OTCBB:HQGE), which controls and operates 10 vocational schools in China under the widely known "HQ" brand and is one of China's leading providers of customized or "order-oriented" vocational education, announced today that it will hold a conference call to discuss its financial results for the fiscal year ended August 31, 2010. The conference call is scheduled for Tuesday, November 30, 2010 at 8:30 a.m. Eastern time (5:30 a.m. Pacific).
To participate in the call, please dial (877) 941-2069 , or (480) 629-9713 for international calls, approximately 10 minutes prior to the scheduled start time. Interested parties can also listen via a live Internet webcast, which can be found at http://ViaVid.net.
A replay of the call will be available for two weeks from 11:30 a.m. EST on November 30, 2010, until 11:59 p.m. EST on December 14, 2010. The number for the replay is (877) 870-5176 , or (858) 384-5517 for international calls; the pass code for the replay is 4390105. In addition, a recording of the call will be available via the company's website at http://hq-education.com/english/index.asp for one year.
About HQ Global Education Inc. ("HQ")
HQ provides "customized training" services to varied student populations by operating its own private schools or cooperating with selected vocational schools in China. By rendering full-scale educational and job placement services, the Company realizes recurring revenues, such as tuition fees, school logistics services fees, off-campus internship management fees, and job placement fees. As of August 31, 2010, there were more than 34,000 students from 25 provinces throughout China enrolled in HQ-operated schools. In line with its "customized education" approach, HQ has established cooperation relationships with approximately 128 enterprise clients and provides training to students who frequently become employees of these enterprises. As part of the program, HQ also endeavors to place students in off-campus internships with the enterprises. HQ has become increasingly synonymous throughout China with superior training to meet employer needs and for producing outstanding technical specialists with immediate jobs and fulfilling career opportunities. For the year ended August 31, 2010, the employment rate remained 100% for the students who graduated from our vocational programs.
For more information please visit: http://hq-education.com/english/index.asp.
Information Regarding Forward-Looking Statements
Except for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product demand, market competition, and risks inherent in our operations. These and other risks are described in our filings with the U.S. Securities and Exchange Commission.
CONTACT: HQ Global Education Inc.
Mr. Guangwen He, Chairman and Chief Executive Officer
(86 731) 87828601
Fax: (86 731) 87828601
www.hq-education.com
RedChip Companies, Inc.
Investor Relations:
Dave Gentry, U.S.
+1-800-733-2447 , Ext. 104
info@redchip.com
RedChip Beijing Representative Office
Jing Zhang, China
+86 10-8591-0635
http://www.RedChip.com
Source: Globe Newswire (November 29, 2010 - 11:24 AM EST)
News by QuoteMedia
www.quotemedia.com
Destron Fearing Obtains Government Approval in Colombia for Visual & Electronic Cattle Identification Products
Receives Approval to Supply Electronic RFID Identification Tags and
Readers for Official Cattle ID Program in Colombia
Nov. 29, 2010 (Business Wire) -- Digital Angel Corporation (OTCBB: DIGA), an advanced technology company in the field of animal identification and emergency identification solutions, announced today that its subsidiary Destron Fearing has been approved to supply SINIGAN, the government organization responsible for cattle identification in Colombia, with visual and electronic identification products for the country’s official cattle ID program.
After a two-year pilot project comprised of intensive product field tests, SINIGAN has approved Destron Fearing’s products, citing their excellent quality, and has awarded the company an initial order of 200,000 visual and electronic identification tags and a number of readers. In February 2011, SINIGAN intends to begin operating a new cattle identification system, and farmers and breeders associations are expected to purchase identification tags and readers through ERAGRO LTDA, the Colombian distributor of Destron Fearing products.
Destron Fearing’s RFID tags and DTR4 hand-held readers will help SINIGAN track and identify Colombia’s current population of approximately 30 million head of cattle. The new cattle identification system is intended to help Colombia achieve higher standards in the areas of health, quality and traceability and should enable it to be more competitive in both domestic and export cattle markets.
“Along with our other recent wins in Latin America, this approval in Colombia demonstrates the momentum and commitment that our organization is developing in the region,” said Dan Ellsworth, Destron Fearing’s Senior Vice President of Sales and Marketing. “We are excited to be able to increase our participation in the Latin American market and we foresee an increasingly strong presence in this area,” Ellsworth added.
About Destron Fearing and Digital Angel
Destron Fearing is a subsidiary of Digital Angel (OTC BB: DIGA), an advanced technology company in the field of animal identification and emergency identification solutions. Digital Angel's products are utilized around the world in such applications as pet identification, using its patented, FDA-approved implantable microchip; livestock identification and herd management using visual and radio frequency identification (RFID) ear tags; and global positioning systems (GPS) search and rescue beacons for army, navy and air force applications worldwide. For further information please visit www.destronfearing.com and www.digitalangel.com.
Safe Harbor Statement
This press release contains certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Forward-looking statements included in this press release include, without limitation, those concerning expectations regarding the expected benefits of the technology, the increasing market penetration in Latin America, and the impact of the new orders on the Company's financial results. These forward-looking statements are based on the Company's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions. Additional information about these and other factors that could affect the Company's businesses is set forth in the Company's Form 10-K under the caption "Risk Factors" filed with the Securities and Exchange Commission ("SEC") on April 1, 2010, and subsequent filings with the SEC. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Digital Angel Corporation
KCSA Strategic Communications
Todd Fromer / Rob Fink, 212-896-1206
digitalangel@kcsa.com
Source: Business Wire (November 29, 2010 - 11:15 AM EST)
News by QuoteMedia
www.quotemedia.com
Monster Offers Common Stock Dividend to Be Paid December 2, 2010
Dividend Increases Company's Acquisition Capacity
Nov. 29, 2010 (Business Wire) -- Monster Offers (OTCBB: MONT) recently announced its Board of Directors approved a one-half-for-one (0.5:1) common stock dividend (the "dividend") of the Company's issued and outstanding common stock, par value $0.001, with a record date of December 1, 2010 and a payment date of December 2, 2010. Each shareholder will receive a dividend of one (1) common share for every two (2) shares owned on the record date.
“I have received numerous calls and emails regarding this dividend,” said Paul Gain, Monster Offers CEO. “Everyone I spoke to was excited to hear about the dividend and eager to learn more about our acquisition strategy. I expressed my personal commitment to keep our shareholders informed as we make great strides in the Deal of the Day marketplace, Health Information, and Nonprofit social commerce sectors.” Anyone interested in keeping in touch with Paul Gain can also follow him on twitter @prgain.
Shareholders of record as of December 1, 2010 will be issued this stock dividend.
About Monster Offers:
Monster Offers is an emerging online technology company specializing in social media commerce and advertising solutions for large Companies and Non Profit Organizations. The Monster Offers company website is http://www.monsteroffers.com. To follow Monster Offers on Twitter, please go to http://www.twitter.com/monsteroffers.
Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the management appointment described in this press release, and other risks identified in the filings by Monster Offers (MONT), with the Securities and Exchange Commission. Further information on risks faced by MONT are detailed in the Form 10-K for the year ended December 31, 2009, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Monster Offers does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Monster Offers
Paul Gain, CEO, 760-208-4905
Source: Business Wire (November 29, 2010 - 10:51 AM EST)
News by QuoteMedia
www.quotemedia.com
Orange County Business Bank reports net income of USD272,000 for quarter ended September 2010
Nov. 29, 2010 (M2 Communications Ltd.) --
was USD 150,000, also down from the USD 155,000 in the same quarter of 2009.
(Comments on this story may be sent to tww.feedback@m2.com)
Source: M2 Presswire (November 29, 2010 - 10:43 AM EST)
News by QuoteMedia
www.quotemedia.com
China Broadband Announces Additional Changes to Its Board of Directors
Nov. 29, 2010 (Marketwire) --
NEW YORK, NY -- (Marketwire) -- 11/29/10 -- China Broadband, Inc. ("China Broadband" or the "Company") (OTCBB: CBBD), a publisher of digital and analog program guides and a provider of value added services for the cable industry, including broadband internet, pay-per-view and video-on-demand services for viewers in the People's Republic of China, today announced several board and management changes including the resignation of Clive Ng as Senior Executive and Co-Chairman of the Board, and the resignation of Jonas Grossman and David Zale from the Board of Directors, effective immediately. Following such resignations, Marc Urbach and Steven Oliveira were appointed to the Company's Board of Directors.
Mr. Urbach, who currently serves as China Broadband's President and Chief Financial Officer, joined China Broadband in 2008. Mr. Urbach has over 15 years of accounting, finance, and operations experience. From 2004 to 2008, he served as Chief Operating Officer and Chief Financial Officer of Profile Lighting and Design and Director of Finance at Mercer Inc., a Marsh & McLennan Company from 2002 to 2004. From 1999 to 2002, he served as Finance Manager at The Walt Disney Company and started his career at Arthur Andersen from 1995 to 1998.
Mr. Oliveira has been Chief Investment Officer of Chardan SPAC Asset Management, LLC since 2008, and President of Oliveira Capital, LLC since its inception in 2002, with focus on investments in Asia, biotechnology and Special Purpose Acquisition Companies (SPACs). In 1995, while a Managing Partner at CSO Ventures, Mr. Oliveira co-founded Depomed, Inc. and Siga Pharmaceuticals. Mr. Oliveira's career in biotechnology began in 1992 as a Vice President at D. Blech and Company, an investment bank that specialized in financing emerging companies in the life sciences sector.
"We are delighted that Marc and Steve have joined our Board. They bring vast financial expertise and years of experience in the capital markets, both of which will be very useful as we begin the execution of our Pay-Per-View and Video on Demand services in China," said Shane McMahon, China Broadband's Chief Executive Officer and Chairman. "The Board of Directors and the management of the Company would like to thank Mr. Ng, Mr. Grossman, and Mr. Zale for their contributions and we wish them success in their future endeavors."
About China Broadband
China Broadband is positioned to be the first national provider of Pay-Per-View and Video on Demand services in China. Through its recent acquisition of Sinotop Group, the Company plans to offer high quality content to viewers in the People's Republic of China through Near Video On Demand (NVOD) and Video On Demand (VOD) services. China Broadband's historical core business operations have been conducted through its affiliate, and with Jinan Jia He Broadband, also known as "Jinan Broadband," the fifth largest broadband operator in China and the second largest broadband service provider in the Shandong Province's capital city of Jinan. Additionally, through its Shandong Group affiliate, China Broadband publishes digital and analog television program guides, newspapers and entertainment magazines. It holds the exclusive license to publish television program guides in Shandong Province, one of the largest regional economies in China. For more information, visit http://www.chinabroadband.tv.
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
Contact
Debra Chen
212-206-1216
Email Contact
www.chinabroadband.tv
Source: Marketwire (November 29, 2010 - 10:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Global Energy Announces Amendment of Certain Material Agreements Regarding the Alphakat Technology
Nov. 29, 2010 (Business Wire) -- Global Energy (OTCBB:GEYI), an emerging leader and innovator in the renewable energy and clean fuels markets with a focus on processing the hydrocarbon and biomass components of waste into diesel fuel, today announced the amendment of certain license agreements and other agreements with Covanta Energy Corporation (“Covanta”), a wholly-owned subsidiary of Covanta Holding Corporation (NYSE: CVA), American Renewable Energy, LLC (“American”) and Renewable Energy, LLC (“Renewable”).
License Agreements:
AlphaKat – Global Energy GMBH (“AK-Global”), 50 percent owned by GEYI, has amended its License Agreement with Covanta granting Covanta the exclusive right to develop projects in the United States with the AlphaKat Technology (an expansion of its existing rights) and extending the exclusive term for an additional 5 years.
AK-Global has amended its License Agreement with American to restrict the license rights originally granted to American, enablingAK-Global’s grant of expanded exclusive rights to Covanta.
Development Agreements:
GEYI amended its Business and Royalty Agreement with Covanta to address the expanded exclusive rights to Covanta under its License Agreement. In consideration of GEYI giving up the right to develop projects in the U.S., Covanta agreed to pay the full cost of registering the fuel produced by the AlphaKat Technology with U.S. EPA and to provide systems to GEYI on a preferred basis for projects outside the U.S. if Covanta elects to manufacture systems.
GEYI amended its Business and Development Agreement with Renewable to address the expanded exclusive rights to Covanta under its License Agreement. Renewable continues to have the right to develop projects with the AlphaKat Technology in the U.S. pursuant to a sublicense with Covanta and GEYI has the right to invest 51 percent of the equity in all the projects developed by Renewable in the U.S.
Asi Shalgi, Chief Executive Officer of GEYI, stated “We are excited about the continued commitment of Covanta to fully demonstrating the capability of the AlphaKat Technology and making it commercially viable. We believe that Covanta’s commitment will accelerate Global’s growth.”
About Global Energy Inc:
Global Energy’s mission is to commercialize innovative technologies which produce energy from waste and other renewable sources, while contributing to a cleaner environment. GEYI is making use of efficient and environmentally friendly developed and patented systems.
About Covanta, American and Renewable:
Covanta is an internationally recognized owner/operator of energy-from-waste facilities and renewable energy projects. Covanta’s energy-from-waste facilities convert municipal solid waste and other types of waste material into renewable energy (primarily electricity and steam) for numerous communities, predominantly in the U.S. For more information, visit www.covantaenergy.com
American and Renewable are both private companies which have played a material role in bringing CVA and GEYI together, structuring the various agreements and will assist in the ongoing demonstration and commercialization of the AlphaKat Technology.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this press release may constitute “forward-looking” statements as defined in Section 27A of the Securities Act of 1933 (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), the Private Securities Litigation Reform Act of 1995 (the “PSLRA”) or in releases made by the Securities and Exchange Commission, all as may be amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of GEYI or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements that are not historical fact are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as the words “plan,” “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “may,” “will,” “would,” “could,” “should,” “seeks,” or “scheduled to,” “proposed” or other similar words, or the negative of these terms or other variations of these terms or comparable language, or by discussion of strategy or intentions. These cautionary statements are being made pursuant to the Securities Act, the Exchange Act and the PSLRA with the intention of obtaining the benefits of the “safe harbor” provisions of such laws. GEYI cautions investors that any forward-looking statements made by GEYI are not guarantees or indicative of future performance. Important assumptions and other important factors that could cause actual results to differ materially from those forward-looking statements with respect to GEYI, include, but are not limited to, (i) unanticipated problems and delays in engineering and construction, (ii) the inherent uncertainties and speculative nature associated with biofuels and alternative fuel sources; (iii) potential environmental liabilities, weather, mechanical failures, safety concerns, labor problems and financing problems; (iv) changes in economic conditions, adverse exchange rates and financial markets; (v) the risk that we will not be able to execute our business plan, such as entering into agreements with strategic partners, leasing land, obtaining loans, etc; (vi) the inability to retain key employees; (vii) changes in energy prices and the high cost of alternative fuels; (viii) Global Energy's inability to finance its operations or growth; (ix) the inability to obtain all necessary governmental, environmental and regulatory approvals; (x) an increase in competition in the biofuel and alternative fuel market; and (xi) the possibility that our technology does not work as well as expected. Investors should consider all of these risks and should also refer to the risk factors disclosed in the SEC filings of Global Energy.
Although GEYI believes that its plans, intentions and expectations reflected in or suggested by such forward-looking statements are reasonable, actual results could differ materially from a projection or assumption in any forward-looking statements. GEYI’s future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The forward-looking statements contained in this press release are made only as of the date hereof and GEYI does not have or undertake any obligation to update or revise any forward-looking statements whether as a result of new information, subsequent events or otherwise, unless otherwise required by law.
Global Energy, Inc.
Yuval Ganot, Vice President
+972-3-609-1690
Source: Business Wire (November 29, 2010 - 10:28 AM EST)
News by QuoteMedia
www.quotemedia.com
Eternal Image Announces Third Quarter Revenue Increase of 37% Over Second Quarter
Company Credits New Product Availability and Greater Internet Exposure
Nov. 29, 2010 (GlobeNewswire) --
FARMINGTON HILLS, Mich., Nov. 29, 2010 (GLOBE NEWSWIRE) -- Eternal Image, Inc. (the "Company") (OTCQB:ETNL), a public company engaged in the design, manufacturing and marketing of officially licensed memorial products such as caskets, urns, monuments and vaults, today announced its total revenue for Quarter Three 2010 increased by approximately 37% over revenue from Quarter Two the same year.
"Acceptance of our products among the funeral industry as well as with the general public continues to grow," said Nick Popravsky, VP Sales and Distribution for the Company. "In the third quarter we updated and expanded both our Facebook and Twitter pages, and we also debuted new product SKUs. We anticipate an equally productive fourth quarter."
Complete financial data for Q3 2010 can be reviewed on the Company's Form 10-Q recently filed with the Securities and Exchange Commission.
About Eternal Image
Eternal Image, incorporated in 2006, is headquartered in Farmington Hills, MI. The company is the first and primary manufacturer and marketer of licensed brand image memorial products. Currently, the company offers urns and caskets that feature licensed images from Major League Baseball™, STAR TREK®, Precious Moments™, the Vatican Observatory Foundation®, and the Collegiate Licensing Company. In 2010, Eternal Image formed a new division called the New World Gift Company. New World manages the design, manufacturing, and marketing of ancillary products such as liturgical candles, retail memorial candles, registry books, memorial prayer cards, and other gift items. For more information about Eternal Image or New World Gift Company, visit www.eternalimage.net, www.newworldgiftcompany.com, or call 1-888-6-CASKET . Also, you can join us on Facebook at www.facebook.com/eternalimageinc and on Twitter at www.twitter.com/eternalimageinc. Eternal Image a public company traded on the OTC: Bulletin Board under the ticker symbol ETNL.
The Eternal Image, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7602
SAFE HARBOR STATEMENT
Statements in this news release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934.
Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include but are not limited to risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may", "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential" or "continue" or similar terms or the negative of these terms.
Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, such factors, including risk factors, discussed in the Company's Registration Statement on Form SB-2, as amended on Form S-1, See www.sec.gov. Except as required by the Federal Securities law, the Company does not undertake any obligation to release publicly any revisions to any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.
The company has no obligation to update these forward-looking statements.
CONTACT: Cambridge Investor Relations
Investor Relations Contact:
Tony Fazio
781/214-9038
Source: Globe Newswire (November 29, 2010 - 10:24 AM EST)
News by QuoteMedia
www.quotemedia.com